Reference sequence (query): batch____ Identities normalised by aligned length. Colored by: property
HSP processing: ranked Search cycle: 2
1 [ . . . . : . . . . 1 . . . . : . . . . 2 . . . . : . . . . 3 . . . . : . . . ] 388
batch____ bits E-value N 100.0% 1:388 MIKIGVIADDFTGATDIASFLVENGLPTVQINGVPTGKMPEAIDALVISLKTRSCPVVEATQQSLAALSWLQQQGCKQIYFKYCSTFDSTAKGNIGPVTDALMDALDTPFTVFSPALPVNGRTVYQGYLFVMNQLLAESGMRHHPVNPMTDSYLPRLVEAQSTGRCGVVSAHVFEQGVDAVRQELARLQQEGYRYAVLDALTEHHLEIQGEALRDAPLVTGGSGLAIGLARQWAQENGNQARKAGRPLAGRGVVLSGSCSQMTNRQVAHYRQIAPAREVDVARCLSIETLAAYAHELAEWVLGQESVLAPLVFATASTDALAAIQQQYGAQKASQAVETLFSQLAARLAAEGVTRFIVAGGETSGVVTQSLGIKGFHIGPTISPACRG
1 UniRef50_P44093 Uncharacterized protein HI1... 380 1e-104 1 54.4% 4:387 2:381 ---LGVIADDFTGASDIASFLVENGLSTVQMNGVPTQSLNSKVDAIVISLKSRSNPVNEAIEQSLRAYQWLKENGCTQFYFKYCSTFDSTAKGNIGPVTDALLDELNEDFTVITPALPVNGRTIFNGYLFVGDVLLSESGMKNHPITPMVDANLMRLMDAQAKGKTGLVAYADVIKGASRVQECFAELKAQGYRYAVVDAVDNSQLEVLAEAVADFKLVTGGSGLGAYMAARLS--GGKKGTNAFTPTKGKTVVLSGSCSVMTNKQVEKYREKAPHFQLDVEQAIHNEN---YIEQLYQWVIANLDSeaPMVYATVPPDALKAIQHQFGVDQASHAIENTFAKLAAKLKQYGVTNFITAGGETSSIVVQELGFTGFHIGKQIAPGVP-
2 UniRef50_Q7N446 Similar to unknown protein ... 367 1e-100 1 49.0% 2:387 3:392 -IKLGVIADDFTGATDIAGFMAQSGWRVVQLLDTPDeaIPQDIDAIVISLKSRSCPIDEAVNNAVKSCRWlqKTGCQQIFFKYCSTFDSTSKGNIGPVTDALMDELQTDITLISPALPVNGRTVIHGHLFVNGQLLNESGMQHHPVTPMTDANLLRLIEQQAQGKADLVDLACVHQGEQAIRVRLNHLQQQNIRYAITDTLSMNDLLPIARAASALKLITGGSGLGAALASTDTGKPLMPYQPEGATPprRTVILSGSCSVMTNKQVALYQKFAPTKALNIDSCIND---PQYAEKLVAWVIQQSEnlAPMLYTTHLPETLQKIQQQYGATTASEAIENTFASVVKGLSQLGFNTFIVAGGETAGKIVQSLDIQQFSIGAPIAPGVP-
3 UniRef50_C3MI57 Paral putative tRNA synthas... 366 1e-99 1 42.7% 4:387 9:391 ---IGCVADDFTGATDVAGIFAKSGMKTTVLIDVPDEGLEVDADAIVVALKTRTIDPSDAVAQSLAALRWLQHRGAAKFYFKYCSTFDSTERGNIGPVLDAMLAALGSDFTTACPAFPANARTIYKSNLFVGDIPLSESGMKNHPLTPMTDSNLVRVLAPQTSHKVAGCYHETVKQGVDAVRAWVSKARADGYGVAVLDAMDDGDLEVIAAAFDDAPFLTGASGLAYGLARTMFEGGAAAAREPEPSTLPGgaVISGSCSTATNGQVEQMLQDHEGFRIDVEQLATGQDV---VKEALDWAKGRLGQKPVLFYATAAPDQVKANQAKFGVAEAGTMVEGALSKIAKQLVDRGVSELIVAGGETSGAVVKSLGINQLDIGNEIAPGVP-
4 UniRef50_D2TUE9 Putative uncharacterized pr... 365 2e-99 1 46.3% 1:387 1:387 MTTLGVIADDFTGATDIASFMVNAGWKVVLFNGIPNKAFdgDMDAIVIALKSRSVPASEAVAMSLSASAWLKTQGCQRQLFKYCSTFDSTARGNIGPVTDALMKSLATPVTLICPAVPDNGRTILNGHLFVKGELLNESGMEHHPVTPMKHSSLKKLMEAQSVGLCGNITLDIVKNHPEKIASEIENKMANKARYLIFDVLDNHDLLTVAKATASFPLVTGAAGLGYAIAALDKQHVSSAKKVAIsgSKGPGVVLSGSCSAMTNQQVEFYKQRASSLALDVEKIINEPAYLETVSAWVK--SHSQDPTAPMVYATQPPQIIELIQKNYGAQVVSDKIESFFSSLAQSLAAAGFNKFIVAGGETSGAVTQGLNIDGMVIGESVAPGVP-
5 UniRef50_A4ITC0 Putative uncharacterized pr... 365 2e-99 1 25.9% 2:387 1:392 -MKIAIIADDLTGANDSGAQFAYHGLNTSVLFQ-PDPNAWHLSNAVVIDTDTRSLPKEKAYEKVKSVSETIKKY-ATLVYKK----IDSTLRGNIGAEIDAIYDTLQPTFMMIAPAYPQNGRTVYQGYHFLHGTLLHETELSRDPKCPIDESSIPRLLAKQTKRPIGVIDYQTLRLGFDKVKEQLDHYRADGIPYIVFDSVSEDDLRDIarQLNEQVVWVGSAGLAYYLPEVYDLQTS-PKTMIIKPNKRPILLVVGSVSQVSRTQLDRVLSLPNVKGIQVDSVQLVCDHQSRITEMEKALRQAeqGFHIVLYSSASSSDIQRVRagRTPIETSNLIAESLGEVAAELIRNgfGAMVLTGGDTAKYVCSQIGATGFELIDEIEPGVP-
6 UniRef50_Q3ACP2 Putative uncharacterized pr... 362 1e-98 1 23.8% 1:387 1:396 MKQIAIIADDLTGASDTGVQFTQKGLRTLVIFDIKNleDAKNVNVVVIDTDSRSLTSSAAYQKIKEVSQVLKPKGYKLIYKK----IDSTLRGNIGAEIDAIMDVITFDFAAIVPAYPKMGRTTIEGQHFLHGVPIDKTEIANDPICPVKDSNIVSLLSSQSKRNIGLVNLQTIRSGIENIKAKVDNLLKKDVQLIVFDSETSQDLKIVTEYLSSsiLWVGSAGLAESLLDALEFTFNDISQFKLLSTENPVLLVIGSISKITQQQLSIILKQPNvvKLDPLNVLKDEQYNNEISrlVEIKLALKKGFDVAFHVNSSPEIVQKTQenIPQNQISNRIADALGIISSqiKEIPLQGLILTGGDTAKSVCKHLGVRGLKLIKELEPGVP-
7 UniRef50_UPI0001788C8A type III effector Hrp-depen... 354 3e-96 1 24.4% 2:387 1:393 -MKLAIIADDLTGANDSGVQLARHGLKTSVLFDMDQDNIRH-YDAVVFDTDSRSISPEEAYQRVSRAAQFLTDAGFDTIFKKM----DSTMRGNIGTEIDALYDVVKPDFMMIAPGYPKNNRTILNATHYLNGVPLAETEIAHDPKTPVTHSYLPDLLKLQTKYAVGEISVRDLEAGAGRIEGKLKEFQEHNIPYVLIDSTEEAHLEFILHITGQLPywAGSAGIANYLPAHYH-ISSKPRELAIAQNQGPILTVVGSVNKNSRAQLKLLLEHTDVVPVHFESYKAVSDSAERTEEmqEVKLHALEGKDIVIYSTAESSDIERaaRGLNHTEVSNEIVRAMGEICAQLLEQgfKGVSMTGGDTAKQICMQWSISGFELLDELEIGVP-
8 UniRef50_A8RH35 Putative uncharacterized pr... 345 2e-93 1 35.9% 1:387 1:385 MPIFGCVADDFTGASDAASFLVKGGMSVQLFNGIPasRVGEGIQAIVIALKSRTQDTGEAVADTLRALGWLKEQGVERFYLKYCSTFDSTPKGNIGPAADAAMEFLGVSYTVLCPALPVNGRVVMKGELYVGGVPLHESPMKNHPLTPMWDARIANLMKPQSKYSCVELWKEQMDRPADEIHAMLSDQAdqEHYYVIPDYQDMEDGERIVELFGDLALLTGGSGILEPLAKHLSRRQDILPELDIRAEGAAVLI-AGSCSRATLEQIAHFQThgFSYKMDPMAMLEGRESLEDAWRFVR-----ENWGTPVLIYSSDTARNVKEVQQYGQERVAEMLEQAAAELAERAVAHGIRRVVVAGGETSGAVTKRLGFSSYRIGASVAPGVP-
9 UniRef50_A8RJF8 Putative uncharacterized pr... 338 3e-91 1 40.6% 4:387 7:414 ---IGCVADDFTGAGDVASFFVKAGLVTVLYNGIPDdtVAEGTQAVVIALKSRTQDREQAVADSLRAFGWLLQEGARKLYFKYCSTFDSTKEGNIGPVADAVMEKFGYPYTILCPALPVNGRTVEKGKLYVNGVLLEESSMRNHPLTPMRESELGRLIEMQSRYK----GISMAGKTKEQWKKEQETlrQEGHCYLIPDYYEESHGKEIAREFCDIIFYTGGSGLAEHVGRLLAEKAMADRdkEKACSRQEALLLAGSCSEATLRQIRSYEKGgpCYRIDAGRVLRGEETAEHVWNIVKM----HPGENMLVYSSDSPEQVRKIQEE-GKEKISFMLEQLTAELAARAAGSGYRRLIVAGGETSGAVIQRLGYQGFWIGHSIAPGVP-
10 UniRef50_C1PBS9 Type III effector Hrp-depen... 335 2e-90 1 23.1% 2:387 1:393 -MKLAVIADDLTGANDTGVQFAKQGFRTVVLfgTQLQPLHLNEDVVVMNSDSRGLEQEEAYEAVFKIAMHSRKLGVSKIFKK----IDSTMRGNIGLEIDAVMDAFQFETAFIVPAFPKSDRITIGGYHFVNGVLIENTELAQDPVCPVNESYLPTLLQSQSKRKVELLSISDVRKGKKHLSELMNKLASEKIplIVVDATTDSELKMIVEATRNLelWAGSAGIAYHL--FDTGQAEEELGKAEIKDRPPVLAVAGSVNSIIDHQIRNLKEKHHVEEisPEEFFYEDRKKREIENVVTIGQDLLKKGDLVVTTNREREavKELQRRFGLsdVGQTIAKSIGMIAARLIGspVCGVILTGGDIAGATCKVLKGDGIRVIGEVEAGIP-
11 UniRef50_A8FHB0 Putative uncharacterized pr... 328 2e-88 1 22.9% 3:387 15:401 --KVIIMADDLTGANDTGVQFVKAGLTASVLFQSSFGDIDqkEDVLIVDTDSRSMSSENAYNEVSQMVQPFLQDESHLFFKK----IDSTLRGNIGIELQALMDIGQFDAAVIAPAYPDAKRTTAYGIHYVDGVPVHLSEAANDPKTPVLTSSISGLIAEQTNVTPKNLTQQTISAELKETSDEVSSLLKHGHQWFVCDAVTSGDLAQIVELFMKMelWV----GSAGLAGALAASVEKKREASQLKKHRPVLIVSGSASQKTNKQFAYVRETHHCLEVKVNPLNILNGREAWERKSVLDQLRTHQNEDILLYTDARPEMVEKmtKGLSRQEVGSALSVCLGRITKDIVqsGITRLFLTGGDTARAICQELGAAGIRLLKEIEPGIP-
12 UniRef50_B1JS75 Type III effector Hrp-depen... 328 2e-88 1 47.7% 2:387 3:402 -IQLGVIADDFTGATDIASFMSDSGWKVVQFIGVPTSncPPNTDAVVIALKSRSIPAAEAIEQSLACLQWLKeaQARQIYFKYCSTFDSTPAGNIGQVSDALMSAAGVQQLVHCPALPQNKRTVVHAHLFVNGVLLNQSGMENHPLNPMRDADLRRVLAPQIHGAVGSLNLDAIQQGTLAIHQRLVALSAQGCNHVIADTLTPADLDQLALALAQQPLLAgpSIFISGAASTLDAASTSGATKFAFPIKRKTVVLSGSCSAMTQRQVSTYCQQAAHFALDVGRCLEVNS--GYINDIADWVMAHseALAPLVYATQPSDIIREIQQQYGEQQASLAVEAAFAGLANELLARGVNTFIVAGGETSGTVVKQLGVNMLEIGQSIAPGVP-
13 UniRef50_C5EPL1 Type III effector Hrp-depen... 328 3e-88 1 39.5% 1:387 1:394 MAVLGCIADDFTGASDAASFLVKGGMSVRLYNGIPdgGQEEEAQAVVIALKSRTQETARAVSDSLEAARFLLSQGVEQIYFKYCSTFDSTPKGNIGPVADALMDLMKVPYTILCPALPVNGRTVEDGRLMVGGIPLHESHMKNHPLTPMWDSRIDKLMEPQSRYSCRCVGEQGADgmAGSGSGETGDRQPGEPFYLIPDYRTDKDGERIASMFGHLALLTGGSGLLEPLARQWTKKLSSQGKIPDNATAGMALLLAGSCSKATLSQIAWYQSqgPCCHLNPREMLEGRQTVDDAWRFIK--EHSSETAAVLVYSSDTPDKVREYQK-LGAEKVAAMLEGAAAELAARAVKAGYTRIISAGGETSGAVTKGLGFSSYWMGESVAPGVP-
14 UniRef50_A8RV95 Putative uncharacterized pr... 328 3e-88 1 37.3% 2:387 1:378 -MILGCVADDFTGASDAASFLQAGGANVILSNGIPEREDEdeAQAVVIALKTRTCPPGEAVDRSMAAFSWLKAHGARMLYFKYCSTFDSTENGNIGPVLDAALERWDIPYTLLCPALLENGRSVKDGKLYVNGVLLEDSPMKDHPLNPMRDSRLKYLMERQSRYPCFNLGAGELERG-------FRPYEKPGHYYLIPDYYEEKHGRMIAKQYGNLPLLSGGSGLLRMIARTWEPDEERSVLTPSRCAAP--VILAGSCSEATRTQIRYYESKGGalRIHPLRFVQGIQTMEHIRAFLE----ENKDQAALVYTSAPPDEVNRIKAEWREspLEHYNEELLAGTAAYALESGRKRIIAAGGETSGAVMQKLEMHTFHIGRSIAPGVP-
15 UniRef50_Q65EJ4 Putative uncharacterized pr... 327 4e-88 1 22.0% 2:387 1:390 -MKIAIIADDLTGANDCGGQLVHYGMDVSVKLDAEFTRRETEG-VVIFNTDSRSLPAAEAKATVKNISEHISRQSFDIVYKK----IDSTMRGNIGAELQAMYEVFQPDFVLIAPGYPQNGRQVIGGIHYVNGVKLEETEAANDPKTPVAESNIQRLIEKQTRNKSGHLSYEDIRRGHGHVRNKLERFRAEGISYVTADSVHESDLQGLALILESLpiLAGSAGLMSCLPKAFNLKERELGQTVPSSDQ-PIMFVVGSMSRTGREQLHELFAGRAAEKIEMRSERVleKRNEFERLKERAADVQRRSKHIVLCTSDNAAETQKisRGLTPVQTSNAVSGALGEFAGELIQahVKRLFLTGGDTAYQVLHQLRIHEIRLLDEVEPGIP-
16 UniRef50_Q2RPK8 Type III effector Hrp-depen... 327 4e-88 1 44.2% 1:387 1:388 MPLLGCIADDFTGATDLAAMLVGNGMRTVLMLGRPKAATESpaDAVVVALKSRTTPAAQAVSDSLDALTWLRAAGARQIVFKYCSTFDSTAQGNIGPVADALAEALETDFALVCPAFPANGRTVYQGHLFVGDHLLNESGMRDHPLTPMRDASVVRLLAAQTPHRVGLIALPVVEAGVPAIDEALRALRATGVRYGVIDALTDDHLRTIGAAAAGHRLITGGSGVAMGLPENFRRQGLLPFRDDSASLpgGAAVLVGSCSQATRQQVAQARPHLPTLILDP---LATPEAGALMAIARAWIDAQPAGAPLMIVGSAAPEAVAALQKRLGAGPAGALIETVLAGLAEDLVERGIRSLVVAGGETSGAVVSRLGITSLRVGAEIAPGVP-
17 UniRef50_Q1YN89 Type III effector Hrp-depen... 326 6e-88 1 40.6% 2:388 33:416 -MILGCIGDDFTGSSDLANTLAKGGMRTVQYSGVPTGDAAPDVEAGVVALKSRTIPVAEAVRQSLEALAWLRSQGCRQFFFKYCSTFDSTDEGNIGPVGEAIARELGAGAVIVCPAFPATGRTVYQGHLFVNDRLLSESGMENHPLTPMRDADLRRVLARQTDAPVSHVPYGVVAKGEDAIADALRQAGADGLCFVITDAVLDADLHATGHAARDLPLITGGSGIALGLPENFRAQGLIGSSTAltGVVGRAAALAGSVSTATRRQVGVHRDAgpTFELGADAVMAGEVTAASLTEWV-----LAQSGVPLIYSSADPETVAAAQQRHGKEAVATAIERLFAATAAALVEAGITRLVSAGGETSGAVVTGLDVQSLEIGPEIDPGVPA
18 UniRef50_Q2BCV3 Putative uncharacterized pr... 326 1e-87 1 23.1% 3:387 33:420 --KMGIIADDLTGSNDSGVQLAKKGFNSTVVMDI-DINVHSHTDVLIVDTDSRGKTEEAAYEAVSKAASLLFQQGFNHVYKKV----DSTLRGNIASELASLADVYQPEAVVVAPAFPKLNRTTLNGKHYVDGQLITETEFGRDPKTPVIESYIPDLLKETVKDKIILLNASLLRGPKDEVFSFIEKELRSGIAWFVCDAETEADLERIARilEKKTVWAGSGGLIDYLPEAL-QLDPVIGQQREEISIRQTLIVSGSLSQVTKSQLESLQRAERSYFIEVNPVDLVKDSLNIDSLLKEAGNAEEDSQFILYVNSSEeaKDAGAAENLTANQVSERIASGLGKAARIFLEkkIDGLILTGGDTAKAVCQELGVSEMELLSEVEPGLP-
19 UniRef50_C0D8V9 Putative uncharacterized pr... 321 4e-86 1 39.5% 3:387 5:417 --ELGVVADDFTGASDAASFMVQGGLETVLFNGVPEaeNIHGARAVVIALKTRTMEREQAVEESMEAFRWLRKAGARCLYFKYCSTFDSTPEGNIGPVADAVMEELGIPYTLLCPSLPVNGRTVRDGALYVNGLPLHESHMRNHPLTPMWDCRISELMRGQSRYPCVAVdiDAQSGAFAGANAKLEELAArgHLYAVPDYETDGQGQGIARAFSHLPFLTGGSGLAGALSRVFTDEEEKNGSLIKEptPGRAILMAGSCSAMTRRQVQAYLAdgFGVRLVPEEIVAGAQSAETVWEQIR-----DAGRTPLVYSSAAPEDVLK-SQQMGRERVAQAIEGLFAGLAVRAVEAGWTRVISAGGETSGAVTRALGCVGYRIGDSVAPGVP-
20 UniRef50_Q3JLF5 Candidate type III effector... 320 6e-86 1 44.4% 2:388 9:396 -PLLGCIADDFTGATDLANMLVKSGMRTVQTIGVPAAGAAVPADAIVVALKSRTIPAADAVAQSLAALDWLRAQGCRQFFFKYCSTFDSTDAGNIGPVADALLDALGGefTIACPAFPENGRTVYRGHLFVGDALLGESGMENHPLTPMKDANLVRVLQRQTPSKVGLIRHDAIALGTCAVRETIDTLRREGVRIAIADALTDRDLYVLGEACADLPLITGGSGVALGLPSNFRLGGLLPERGDAAALpgASAVLAGSASKATHAQVAAWRAERPALRIDPFAAARGEPVVDQALAFARAHLPQ----PVLIYASAAPDEVKQVQQALGIEAAGHLVEATLAAIARGLREMGVRKFVVAGGETSGAVVQALGVKALRIGAQIDPGVPA
21 UniRef50_Q5WLA6 Putative uncharacterized pr... 319 1e-85 1 21.8% 2:387 1:394 -MKIAIIADDLTGANDSGVQLAKAGLDTVVWLNG-KGSSENRAEAVVVDTDSRALSPKEAKAAVHAAMSALAPYNPNLIFKKV----DSTLRGNVGAELEATAEAWQPECILLAPSFPANNRTVEDGILYVNGTPIGETEFARNEADPVSDSAISDHIGRQFHGAIAHIPESLWAEKPETISAWLDRNIANEQTVFICDAVSMETLERIAAFSQQQplLAGSAGLSNALAQTMVSGTNTPFADHPV-SSDPILYLVGSMSEVSKTQVAHLLMHPQTEGIRLHAaaASNDRHTQAKEFERVVAAAEkgKIPVIFSGTERQEVAEVYdnTAISELAKRIADTIAAIGSKLMdrHFQAIIMTGGDTAKALCRRLSIDELRLLDEFEPGIP-
22 UniRef50_Q221V6 Type III effector Hrp-depen... 318 2e-85 1 46.0% 1:387 1:386 MKKigCIADDFTGATDLANNLVRAGLRVVQAMGVPAQPLDADADAVVVALKSRTLPVDEAIAQSLAALRWLQAQGAQQIYFKYCSTFDSTAQGNIGPVAEALMDALGTDFTIATPAFPDNQRTVFKGHLFVGDVLLNESGMQNHPLTPMTDANLVRVLQGQCRRPVGLIDYKVVAQGEAAIRTRIDQLRAQGVGLAVVDAISNDDLLRLGAALSDMPLVTGGSGVAIGLPANFGIAPSSTASALPRATGLQA-VVSGSCSLATNRQVLAFIQAgpALGIDALQIAAGVDVTTQA---LAWAAPLLSQGPVLIYSTADANAVKAVQAQLGVEEAGAMVERTLAAIALGLVALGVRQLVVAGGETSGACVQALNITQMKIGPQIDPGVP-
23 UniRef50_C0D506 Putative uncharacterized pr... 318 3e-85 1 37.0% 1:387 1:420 MAVLGCIADDFTGASDAASFLAAGGMAVRLFSGIPEGEAEKggAALVVALKTRTQPAGQAVRDSLAALRWLRNQGAGQFYVKYCSTFDSTPAGNIGPIADAAMEFTGSPYTLLCPSLPVNGRTVAAGHLYVNGVPLDQSPMKDHPLTPMWDSFLPALMEPQSRWECLLLERACLSYSRETVEAGlaRNLGLDRFYVVPDYGNTQDGERIAALFGHLPLLTGGSGLLEPLARSLTGGGKAQerQTGVFTSSPALLLAGSCSPATLAQIAYFESRGGIAK-KLEPALVLDRSPEEAAQSLWRFLENHRSQPVLIYSSETAQQLQATRKLAGGRPLSPLLEETVALLASRAVERGWRRLIVAGGETSGAVTRKLGLNSYDIGASVAPGVP-
24 UniRef50_A1HLP5 Type III effector Hrp-depen... 316 8e-85 1 24.3% 1:387 1:386 MQKLAVIADDLTGANDTGVQFAKQGLTVEVLLGSQDAA-ATQADIIVIDTNSRAISSAEAYRRVAQAAAIVKASGIAAVYKK----IDSTLRGNLGAEIDAIMDTCGQAAAIVAPAYPQNGRCVIGGYHLLNNIPLEATEIARDPRCPVKESHIPTLIAEQTRRPVGHLSFKTLLKGEDATQAALEELIGCGKEVIVCDAWEDKqiAAAAANLGKPVLWVGSAGLAQWLPTVLG--------LTARKQSSPVLVIAGSVSGVTRGQVAKLKQNANVKGIEVdaLLAEPTRSGEVKRCCAEAAAALREGYDVVIASGYAEEVVEHTKAQgaQQVGDIVAGALGEIGKGLaeLTLAGMVLTGGDIAVSVCRALGAASLSVASEVAPGIP-
25 UniRef50_Q8CUU5 Hypothetical conserved prot... 316 1e-84 1 23.5% 1:387 1:392 MAkiAIIADDLTGANDSGVQLTEKGMDTSVLFEIPD-EIEFLSEGLVIDTNSRALNKADAISITSQATNFIKKLGYQHVYKKM----DSTLRGHIGYELKVMEFELDADLVLIAPAFPSMGRITKNGYHYVYGELISETEISKDPKHPVTESHIPTLIKNQIGEDVGLITKKEYED-ELLLRSKLDSFQKENIKMVVFDAESEEDLRTIaaSINQNVVWAGSAGLAEVVPEVLHLE--KEKQVATYNNSNITMTVCGSLSQMTQKQVQYAMKQTGVLAVELDpkMFQQDWDTYKTIYMEKCISGFKDDKDVVLYVPSNEVIRKDVQEIgkNQLGETISEKIADLVSTIKEekIDRFVLTGGDTAKATAQSLGAVGIHLIKQLEAGIP-
26 UniRef50_C0C2Y1 Putative uncharacterized pr... 314 2e-84 1 34.6% 4:387 8:393 ---LGCIADDFTGAGDIASFLTRGGLRTILISGIPagDIPKDADAVVISLKSRTAPVREAVRDTLESIRSLETLGCERFYIKYCSTFDSTPHGNIGPVLDAVLEYLNETCTVLCPSLPVNGRTVKDGILYVDKIPLSKSSMKDHPLTPMWDSRIAVLMSGQSRYPCLELGRKYYSCTSEEAYDYIKSAagHSHYYIIPDYENEEDAAHIIRLFSDMRVMSGGSGLAAVLAGGlaQRKDVHVRQMDIRAEGASLIVAGSISKATTGQIHFYKEQgpYYKISPEQLWKRTETASSI--WNEIKQRLTGEHDSVLVYCSDSREDVKKGQELGGQKFAGLLEDTLAKLAAKAAEEGIYKIIAAGGETSGAVTKKLGYKAFYTAQSVAPGVP-
27 UniRef50_B0KBL7 Type III effector Hrp-depen... 313 6e-84 1 24.3% 1:387 1:380 MYRVIVIADDFTGSNDTGVQLVKHGYYVITLIGTAGVKKYEdaDALVIDTETRSIPALVAYEKLKEISNIVGEYKEAVVYKK----IDSTLRGNIGVEIKALREGLKPELTIFAPAFPKNGRTTEKGVHYLKGVPVDKTELARDPKNPVTTADVKKILEEGLKVPVKHKVLEEISR---DLRKDIEKEMRE-YDVFSFDAKTDDDLIKIATslGKKTLWVGSAGLAEALIASLEKKE----------KKNPVLVIAGSVSQVTRRQVFKALEDSRIVLVKLDVKRALSHPEEEIDRIRKIVLDFMNAAKDVIIASAAEEdiAARGKGLSPQDTSEVLAQFLGEVACSIVEarPGGLVLTGGDTAIHVVKSLSTAGCRINSELEPGIP-
28 UniRef50_B9Y619 Putative uncharacterized pr... 312 1e-83 1 27.3% 1:385 1:386 MIKTGIIADDITGAQDIGVMLAKQGLTTR-ITQKTDGHFPADTEVLIQDTDSRFDSSLTAYRKVRQAASRMKAEGCGRFYKKTCSVF----RGNIGAEFDALLDETGEDFGIVSAAFIKNGRQTIQGIHYVHGQKIAASPFRSDPVNPIHESELARIIQEQSQRKTKIATLAEIRRGPEALKAFVER-SKQECSYLIFDGETQDDLKIIAAAVHQEKIFLGGSGLAEELAIYWAEHAPQPRTFPTLGT--RTMILAGSLTPQTHKQIQLFEQTPQSCSvdPLALFDKQTALRQAEQaaRMKVALDKDLIPLVYFQNDAAVVRQTKDrwTETQTAQELSSRLASLVHdiRDSSVSRVLSAGGDTSARFIEHMKMEMMEIVDELEPG---
29 UniRef50_B4BR45 Type III effector Hrp-depen... 311 3e-83 1 21.6% 2:385 1:388 -MKIGVIADDLTGANATGVRLAKQGFKTATFVRNASLTGIEKYDAVCIDTDSRYSPREIAEARVRQAVNYFKQWNVE----VVCKRIDSTVRGNIGIEIDTVLRELGdsVAVVVPSFPDSGRMTTGGYLLVDGVPVQETDVAKDPLIPVHQSFIPALIQQQSIHSVALIGLDAVLHGAECIAQRLREEIQHGNRIIVIDAVNDEHIETIAFaiKDKIIVPVDPG---PLTAYYARL-----YFHQQLHADKILMVIGSVTSLTGRQLHYLLanANPVYVNPEKLAssNSWNEEVERATAVSLERLETENILIVTTHHPakALSAIEQVSEDALAKRITDGLAVIGRKIIehPICGCFTSGGDVTASLCAVGRANGIEIEDEVLPL---
30 UniRef50_C6D3S6 Type III effector Hrp-depen... 308 2e-82 1 25.3% 1:387 1:395 MKQISIIADDLTGASDSGVQFARNGLKTQVLFDwaIPDDHSELDVIVIDTDSRSIPGELAYKRAASAAAALKDKGFSFIYKKM----DSTLRGNLGQEIRGVMDSFGFAAAFIAPAFPRIGRTTVGGVHYLNGTPIHETEMARDPKTPVPDSRVAYVLQEQSGLASVNVELALLRKGPEAVRQFIEEQLRHTVKLFVFDAETDEDLAIIAALmqSGVLWGGSAGLAEFLITPDPTRSAERYEK--QSAEGAVILVAGSISAITREQVAEVNRQANVAALEMDPLAAIGPVEEREREiaELQLAIATGKDISLHAGSSPEQVRAAKegLDSSDVSNRIADTLGQITSQVAasSVQGLVLTGGDTAKAVCRYLGVSGFELHHEVEPGIP-
31 UniRef50_UPI00019080A4 type III effector Hrp-depen... 307 4e-82 1 35.9% 4:387 9:360 ---VGCVADDFTGATDVANIFARAGLKTTVLIGVPEDDRDIDADVIVVALKTRTTRPQMAVEESLVALRWLRGRGAQKYYFKYCSTFDSTAKGNIGPVADAMLAELGQSITIACPAFPANGRTVYKGNLFVGDVPLDESGMRNHPLTPMIDANLLRVLGPQSRAEITGCYYETVRQGASAIAVWAAPIHGRGVGPGLWLAR---------------VLLPAGTVATLPLRLTWTKATEPSSP--------------GSCSVATNGQVKAMLADHEGFRVDLSKLAEGGDVVGEA---VEWASSRLGRKPVLIYATALPDEVKENQRQLGVAQSGEMVEAALSSIARRLVEKGVSDLIVAGGETSGAVVKSLGVDQLSIGNEIAPGVP-
32 UniRef50_B5Y707 Conserved protein n=1 Tax=C... 304 4e-81 1 19.6% 1:387 1:379 MLEVAIIADDFTGANATGILLKKKGLKVTTLLKPNSNIDQVNAEVISISTNSRSIDPKEAYKRVYEATKTVIKSTPY-----VAKRIDSTLRGNLGAEIDAVLDAAGEGyaAVVPVYPKSGRVCVGGYLLVNGTPLQLTEVAKDPKCPIRSSNVKELISSQTKRSIANITLDIVAGGRKAISDAFFQVKED---IVVFDAVTDDDIENIASAlsQEKIICVDPGPFTA---------AFIEQKMGFQKQDGIFLILGSVSELTTAQLNYLLKRKEAYICKISVPEILTNEEAAIKKALEVLIQHYKPGLIMGISTKGDASDvsIKAQCDPEEISNRINETLSRIAYtvKDKPFSGIYITGGDTALAFFDVLGINEFTVESEVLPLAV-
33 UniRef50_A8MJU4 Type III effector Hrp-depen... 299 1e-79 1 17.9% 1:386 1:392 MLKLVIIADDLTGANATGVLLARQGFRAATFLQLNEdnSKQDFDVLSTTTDSRGLPSEEAYDRVHKVVGFFKDQEVQLFSK----RIDSTLRGNLGAEMDAVLDGLPEDYVAVVVPVFpsERIMVGGYLLVNSVPLEKTDVSKDPKTPIHHTFVPKMIQKQTKYSVGFIPLSKTLKSSELVKEAILEERGKGHRVIVIDATTNEEIALIAKAVKDTKLNV----IAVDPGPFTAALAKELIEEPNKIPGQRVMLVIGSVTNVTRKQIDELKldPLLVAVNAKNLIYPETLETEINRVVERLMNNIKNHEIvvVTTEKEEEVLNLKdgITEEEASERISDGLARITKKVMERriGGLYTSGGDVTVAVCKAFKSSGIAVKDEVLPLA--
34 UniRef50_C2KZQ3 Inner membrane protein n=4 ... 297 6e-79 1 17.9% 1:386 1:393 MPKCIVIADDLTGANATGVLLKKMNYSAYTVLNAERLELseQCDCVLYPTDSRGIDQDLAYRRVSNVCNLLKNEDT----KVYGKRIDSTLRGNLGAEVDAMLESLGEDYVAIVVafPTSSRIVLGGYMLVEGLPLHKTDIAIDPKTPVNNPEVAELFRKQSKYPIASILMKDLLHGKHYLADCMKKLAEEGNRIIVVDCVSQEDIDLIADAVETSKLKV----LAVDPGVFTASLVRKRIPPTEKKEKNKVLAVVGSVNPHTRLQLEELWLSQRCKNVFVETKALLEGEEQWEQEVQRVVDAILQddKDRVFTVTGDGIYPENRVDLGkeEISNKMNLAFAEIAHRICERefKGIYSSGGDVTVSICKRFKTAGLSLEEEVLPLA--
35 UniRef50_B0UL63 Type III effector Hrp-depen... 295 2e-78 1 41.1% 4:387 20:405 ---LGCIADDYTGASDLANTLTRAGLRTVQTIGVPGDDLdpGIDAVVVSLKSRSIPAEQAVARSGEAEAWLRARGAAHVLFKICSTFDSTDAGNIGPVTDALRRSSGAAIALVTPAFPETGRTVYQGHLFVGAVPLHESPLKDHPLNPMRDSNLARVLARQSRDPVGLVDLATVARGAEAVRARLDALAAEGKGAAIADAVFDADLAVLGQACLSDPVSTGASGLGLGLARALVarPADAAEGLGAPVGGPAACLAGSCSQATLGQIAAAEAAMPVRRLDPERLLAGAD---EVEEALSWAAERIGAGPVLIASSATPQAVADLQARHGREAAGHAIEAAMARLAEGLVRRGVRRLVVAGGETSGAVVDALGLPAFRVGPEIAPGVP-
36 UniRef50_C5ELY5 Type III effector Hrp-depen... 294 4e-78 1 21.0% 1:385 1:391 MITLLIIADDFTGALDTGVQFAAAgvRVVTDTRYDYRKADEGVRVLVMDAETRHLDSRDAYEVVWNITKRAMACGIPFIYKKT----DSALRGNIGSELTALLDASGQDILPFIPAFPQMGRTTREGIHYINDVPVKDSVFGKDPFEPVTCSFVPDIIHQQSNIRVEVIKEEDGDGNKALMEDGQAPDDGPLSRIAVYDARSQEGLTAAALDlgRLSVMAGCAGFASVLPGLLGLEGRESYAPEFIP---RFLAACGSVNPITKKQLDYAEEHGFTrkLDRGYWKTDEGQAVLKKWMLQCRLERRSILDSNDYDGTDETMEYAREKGISLDEVRTRIADSMGYILKHMVERGlsTLLITGGDTLLGFMNQIKVCEMEPVCEMAPG---
37 UniRef50_C1NBK7 Predicted protein n=1 Tax=E... 293 6e-78 1 21.4% 2:385 1:383 -MKVAIIADDLTGANATAALLSTQGFTTLTCLDNP--EYAEDYDVVSFSTDSRSVSYQEAYARVSRYLEIINPEITT-----ISKRIDSTLRGNLGAEVDAVIDRFPQLMAIVVPVYPSSGRICVGGSLLVDGIPLQNTAMRNDPKNPMTESSVMELFRKQTNKNLGYISLSSVLAGVNTLVHELKTLYHKNVRIVVIDATTDEDIHQIATAVLKtpFFCVDPGV-------FTAQLAYLRYSSGRKRTNKIFVTIGSVSELTQRQIRKLRYERQVCilPAETLIDYAFHPETASELVAHLTSKTDQYDVviDTVELPEHilSAKYSIDENEVTCLINKGLAEITAQVLesPFSALYSSGGDVVVAITKRLQGNGVILKDEVEPL---
38 UniRef50_Q89PE1 Blr3541 protein n=1 Tax=Bra... 293 7e-78 1 33.2% 2:386 10:394 -PVFGVVADDLTGGMETAAMLIAAGIDCAFVTDPELVATIGDIPAIVVAQKTRVIPADEAVARSGKAARALLARGARQIFFKYCATFDSTDRGNIGPVADMLMQLTGADHTAFCPASPSLRRTVYNGHLFLGTELISDSPKRNDPLTPMTDPDLVRVLQRQTPTRVGLLAHPSVSAGPAHLEQAIASATGQGVRYFITDAIYDRDLDVLAELTSDWKLMTGNATIVQHYPAIWKAQgpTSNRARLPAVDGSGVVLAGSCAERTLEQLAEFERHRPVLRMN---LLAADDVGSAVGVALDWVRPRLKDGPIAISTSESPEVVKMVQERYGREGAAQLAETILGRLAVSLRGAGVRRFVVAGGETSGSIVDHLGIRSLRVGPYGGPGI--
39 UniRef50_B5F811 Putative inner membrane pro... 289 1e-76 1 23.8% 2:387 1:382 -MKMMVIADDFTGSNDTGVQLAKKGARTEVMLS-ASQKPSRRADVLVINTESRAMPADQAASAVYAALswCETSPAPLVYKK----IDSTFRGNIGAEVTAAMRASQRKLAVIAAAIPAAGRTTLEGKCLVNGVPLLETEFASDPKTPIVSSRIAEIVALQSEIPVYEVFLQDVRRGG--LSALLTAYAAEGEGIIVVDAVEERDLTLIAQAACemPLLVGAAGLANALPVELFMQDRQRL---------PVLVVAGSMSEATRRQVDNALCRGRAEVVDIDAARMVSDSAEqaSVVEQACALLSQHRHTILRTSRRAEDRQLIDaaMSRQQLGERLSQRLGVVTLNIIEqrIGGLFLTGGDIATAVAGALGAEGYRIQSEVAPCIP-
40 UniRef50_D2THD3 Putative uncharacterized pr... 286 1e-75 1 24.4% 2:387 1:382 -MKMIVIADDFTGSNDTGVQLAKKGARTEVML-TPEQKPSRRADVLVINTESRAIPAEQAAKAVQQALawCEGDRMPLVYKK----IDSTFRGNVGAEVTAAMRAARRRLAVIAAAIPAAGRTTRDGLCLVNGTPLLETEFASDPKTPILSSRIAELVALQSDVPVHEVSLDAVRRGELSALL--AAYAAEGECMVVADAVEDRDLSLIAHAvkEMPLLVGAAGLANALP---------VRTFMQAKQELPVLVVAGSMSEATRRQVEKALCHGRAKVVDIDalASAQAEQEIASVVEQACALLGQRHHTILRTSRSAEDRQMIDsgVSRQQLGEQLSQRLGKITLRIIErrIGGLFLTGGDIATAVASALGAEGYRIQSEVASCIP-
41 UniRef50_Q65WI8 Putative uncharacterized pr... 286 1e-75 1 21.2% 1:387 6:380 MQKL-ILADDFTGANDTGIQFVKNNIKVDILLDISKG-YSGKSDVLVFNTDSRAVSIQEAKERVTRVLSLYEGMS---VYKK----IDSTLRGNIGAEIEACMDATNTLIAFICSALPDAGRIIKNGICYVNDVPLLETEFATDPKTPIISSSVKEIITSQTDIPVIEVMHDELCR-PMVVNAKIKQAIAHNQKVIffDATTNQDLVRisNSLDESVLLIGSSG----LAGCMTMRKAIL----------PMLFVVASMSEKTTQQVNYIRHDETNFVIDLDTELLL-SSNQYNDSVIKQALAQFELGKNVIIKTDSSIEARNNVDNLsrAELGDHICMKLSALTKEILIkqLSAIFLTGGDIAIAVAKALNADSYHIAGEVENGVP-
42 UniRef50_C9N2C7 Type III effector Hrp-depen... 285 2e-75 1 40.9% 1:386 1:388 MPTLGAIADDFTGATDLATMLVARGHRTVVTVGppEGTAVRDADAVVVALKSRTAPVDEAVGTSLAALRALRRAGCERFYFKYCSTFDSTPAGNIGPVTDALLAELGERRTVVVPAFPATGRTVYKGRLFVHDELLDESPMRHHPLTPMRDSHLGRLLTPQTRHPVRLVGLDTVRQGGDTLRAALDAPELAD-SLVVVDAVTDEDLVTVCAATTHLALVTGAAGLALGLTGP---HPDAARATPASRPGDPGVVLSGSASSATRAQVAHARARLPHRKLDIPALRA--DFTGEVARLVAYVRRsePGKPPLLHSVDDLGDVERTAPGGGPA-ASELVERALAACATALVAAGARRILVAGGETSGAVVTALGVRTLSIGAPIAPGV--
43 UniRef50_C9U0G6 4-hydroxy-3-methylbut-2-eny... 283 1e-74 1 52.4% 71:387 3:297 ----------------------------------------------------------------------CKKNNCQQFFFKYCSTFDSTPKGNIGPVTDALLEALGEEFTVICPALPVNGRTIYNGYLFVNGVLLSETGMRNHPVTPMTDSNIMRVMESQSRGRAGNISSTIVDQGSDAVRDALRKLQSEGIRYAVLDALNDQHIETLGRAVSQMKLVTGGSGLADEMARAWTQLRGkaAEAAGAPVKGRTVILSGSCSQMTNAQVAAYKAKAPALAMDVEKAIND---AAYIDVLAEWVLAQsdALPPLVYATMPPEALKAVQERFGGERASAAIEDLFGQLA-----------------------KRLEAEGFTIGPQIAPGVP-
44 UniRef50_C6VYK7 Type III effector Hrp-depen... 282 1e-74 1 24.0% 4:387 8:424 ---LAFYGDDFTGSTDVLETLERAGIRTALFMAPPTPEDlpDIRAFGIAGMTRAMTPPQMEKTLMPAFAALKKSGARHIHYKVCSTFDSSPagSIGKAIEVGIEMFNPRFVSLIVAAPALGRYCAFGNLFArhRLDRHPSMSKHPTTPADEADLRLHLSKQTSKTCGLLDILQIEGEPREAAAALENTVREND-IVLFDALYPHQMLRIGELIdaPQFSVGSSGVEMALTACwaGIARNRTEWPEPGEVSPLLVVSGSCSPVTSRQITYALARGfeIALDTPAIATGMHDPTFADDTQKVVEFLRRGRSVIIHTSKSTKDErgLSATEIQTRTSSLYGEALGRIAraMASISVRRLVIAGGDTSGAVAKTLGINALSMIAPLSPGAP-
45 UniRef50_C0D2X6 Putative uncharacterized pr... 281 3e-74 1 20.8% 3:387 18:399 --ELMIIADDFTGALDSGVHFAERGIRTRVIVSMEDDRSWEetTVLVVDAETRHASPEQAGRKVHAIVSDGKKAGIPYIYKKT----DSALRGNIGSELEAALRASGEQVLSFVPALPRMNRITKGGKHYIDGVPVSRSVFGKDPFEPVTRDDIEEIIGLQSKIPV-------------TIAEDPEQLSGIESGIVAYDARSEADIERIgaASGQSRLLAGCAGFASILPTLLGLE---RREPEAAALENRLFVICGSVNPITKKQLDRGEQAGFPRfmRPEEKLDREfrSGDGERRVRQITEAGSGKDCVILDTNDREGTPDTLegMDTEAVRRRIPETLGIILKQMLDQGLNAvlVTGGDTLLGFMKEIGQWELKPIRQIRPGCV-
46 UniRef50_C0CYU6 Putative uncharacterized pr... 281 3e-74 1 21.8% 1:386 7:395 MINTVIIADDLTGANDTGAILAQNGFKVGTILKTDHMEQFEDYDVLCISTNSRGISGTEAYARVQEAAALFPRNES----ILYSKRVDSTLRGNVGAEIDSILDYLGEDyaVVVASFPGSGRTCIGDILLVNEVPLQMTEVAKDPTAPVHTSRVTEIIRQQSRHSVGYIGLEKVLESSGKLLEQLLE-TAKQHRIIVMDARTVRDIEAIAACCAASGLKIA----AIDPGSFTAALAGNLFKHKKEAIQKKLLCGLGSASDLTRQQLQYLkaNPLVVRMNAGEFFRADRRAREMERVKEAVLRSEESHGILVITTTESKEdvDGAEHCSKKECAGVITDTIAQVLYDLVQerVGGVYASGGDVAAAFCEKLGISGFNVKGEVIPLA--
47 UniRef50_D1Y7W3 Putative type III effector,... 280 7e-74 1 18.1% 1:387 56:430 MLRLLILADDFTGALDSGVQLAQCGAHTHVTTNLDVskDDARDSVVVVDTESRHIDPRRAFEIVRDIAGRAVKSGVPVIYKKT----DSALRGNIGAELEGALAGSGAKRLLFVPAYPKLKRLTIEGIQYIDGVPVNESVFGRDPFDPVRESSVAKIIGLQSTLPVVSV-----------AEGAPISVTAERREILVFDASSDEACAAIAKQLgeTTVLAGCAGFAGHLPQLLGLR---RPLPPVTLEAQGLLVVSGSLNPITTAQLEYARSSGfaYRLTSSQMQEGIPAGPEGDRILDDIATLYGRNKRLLLYGAPPEEGVG---SAALEEKSRAVAGLLGELVRQLYRRGLRGVfvTGGDILSGVLAHMKCSRMRPLCEIESGVV-
48 UniRef50_B1KVV6 Putative uncharacterized pr... 277 6e-73 1 18.7% 1:386 1:403 MLNYVIIADDLTGANATGVLIKKLGlpVTLMNSLRKDDLEKSYDTVLYSTDSRGVEKEDAYERVYQATEFFFSPNV----KVYGKRIDSTLRGNIGSEIDGMLDALPEgiAAVVPSFPEANRQAVGGYLLVNGKALEDSDAAKDGKKPINSSIIEKLVKEQSKYEAASIYIEDIKKGCENLQNKILKFYNEGKKLIIFDALDNNDLEIISKALINtkFISVDPGpaEVIKQHIVLDKKNKKKQEIKKDknKVLMAIGSITDTTRAQLERISKDRDIFKVDINSRAILGDINTKHKEIDRVINKVIENKdcVVLDSLYEEVRINLDEEatKEFLSQIMNTSVAEISYRIMKesIKGIFSSGGDISVSICRKFNSAGLELLDEVMPLA--
49 UniRef50_A6WAX3 Type III effector Hrp-depen... 276 8e-73 1 43.2% 4:387 2:421 ---IGAIADDFTGATDVAVAFRRAGLRVAVHFGVPTAASAagLDAVVVALKSRTIEPTEAVEQSLQAARWLQDQGVRQLYFKYCSTFDSTARGNIGPVADALLELTGAATTVVVPASPAHGRTQYLGNLFVGDVPLAESPMRHHPLTPMTDSNVQRLLQGQTTHPTALLTRSVVARGAAAVRQSLQAAAAAGTDYVVVDALDEQDLLTIGQACVDLPLLTGAAGLAGGLGAALAQRERAVSQRAAGTASPPvaVLAGSCSARTLEQLTALRTAAPGSSAHPAHFLDapDAAALAEQALNWYEQQDPAGppLIYSSQPPQQLRAAQQALGVERASLILEEATGLIARGLAERGVRRLVVAGGETSGAVVTALGVSDGLIGSEAAPGVP-
50 UniRef50_B7UKV8 Predicted inner membrane pr... 275 1e-72 1 21.0% 2:387 8:372 -PSILVVADDFTGANDAGVSLAQVGHTVDVAFEMP---YHGDASVWVINSDSRAMDPKLAAMKITSLMSHLPLANNPPL---VIKKIDSTLRGNIGAEIEALMKACGITGAVIAPAFPQAGRTTVAGECWVNGVRITETEFASDPKTPVLSARIADIIRLQTAIPCQPVTVSQ-----------LSHLSYEQPWIGVIDAQTDSDLDRIAAAVMQAklLVGSAGICDAVARRSAIMPPPT-----------VLAIIGSMSEIAQRQIATLHSHPRITQidVEHILAGNASDYDAR----IVQALQKGDHCIVHTCNDSVARHQIDtqMSRAALGEKICRFLGELTRqlLRTMPDALYLSGGDVAMATASALGATGFRITGKVAQCVP-
51 UniRef50_Q2RKJ5 Type III effector Hrp-depen... 273 1e-71 1 23.0% 1:387 1:385 MEQISIIADDLTGANDTGVQFCQHGFRTMVIIDAANVevGQDKDVWAINTDTRHLAAPEAYQRVYEITLKLKKAAISRVYKK----IDSTLRGHPGAELEAVMDAWQADLALVVPAYPANRRLVVDGHLLISE--GMETAAASVSLTPGDacHIPTVLQGEMGRRVGQINLATVRQGVKELVAAL-EAARTNSQVLVLDAADEEDLRNIARAISRfvIVAGAAGMAAHLPLAW---NLKPVPNNPLNKKGAILLVAGSRNPVTAAQVQRLAEVSACQAVKVeeAILTGEPAVEIERVLQEVTTQDAGAGLIIIAVDS--LFQTIDRDRVSNSGSKAIALALGTITSRLlmRRISALVVTGGDTAVHVCRALEARGINLAADLLPGIP-
52 UniRef50_Q1ZB63 Putative inner membrane pro... 273 1e-71 1 19.9% 1:387 1:375 MDSFVVIADDFTGANDTGMQFYNQGCSVAVSLINEAGEF--DCDIVVYNTDSRSMSQEDAKTEIFKVIDHCSITKDTFIYKK----IDATFRGNIGSEIEALIDSTHFSFAILCNALPSKHRTIEDGKCMYRGQGVTKSEFATDPKTPVISDSITEIIASQSSINVYSICKYDLRDSIKAAEKDPSTNV-----VFVVDTKTNDDLAYIGQTIadGGILIGSSGLASHLPPSVYKQDFI----------KPSLVIAGTMSPVTINQTKVAVeaAIVYFVDIHSIMKDQDYLDKC--LAGIIPILDDGRNCIIQSAKSEQDRFDVDagLTRADFGSFISGFLGNLASAITHrnLSGILFTGGDIAISCAASLGSKSYTIKGEILPCIP-
53 UniRef50_Q8RGQ9 Putative uncharacterized pr... 273 1e-71 1 19.7% 1:386 1:386 MQKYIVIADDLTGSNATCSLFKKIGLRAASILKLQ-GDTNYDVDVISYSTASRGLDKEEAYKKVSEAIKILKNKDV----LVYNKRIDSTLRGNIGTEINAMLDNLEdrIAVVVPAYPDSGRIVVNKTMLVNGVLLENSDAGKDPKTPIKTSCVESLVQKDIKYSSTYFTLSDISQPIEEIAKKIQEAIKKS-RVLIFDAVNNEDIIKISKVIIQsnIITVDPG---PFTLYYSKELQKKNHL-----EKKILMVIGSVTTTTKKQIEYILQEefLVKMRVEDFFEEESCSKEIERVISFIKKGIESYDLFLVTTSPIGDEKKADLQKLAENLNTTVEEISKIIANTLTKTAVkgIYSSGGDITIALLEKLKAIGVEIREEVIPLA--
54 UniRef50_UPI0001789BD7 type III effector Hrp-depen... 272 2e-71 1 24.8% 1:387 7:432 MPklCFYGDDFTGSTDAMEALAKSGADTVLFLDPPPPELLAevRCFGVAGVSRSMTPDEMERELRPALERLHAYGTAVVHYKVCSTFDSSPrgSIGKVLELGRSVYpqRYVPILVGVPALKRYTLFGHHFAayRLDRHPTMSRHPITPMRESDLRLHLREQTDLPVSLMEWTALDGVPEEVSARLEHRLEVGEpaLLFDVIDDPRLEAAGRLMWREafVIGSSGVEYALAAHWAKEgpGGARLQAAEQADQLLVVSGSCSPVTQSQIAWALKRGYaiRVRARDWLEPGRADEARRSLLKQALpvEQGRNIIVYSADGPEDPAIaaRGMEPADSGRLIGTQLGRLTSDLlaTGLRRILIAGGDTSGYVTRELGIYALSCLSAIVPGGP-
55 UniRef50_C5F752 4-hydroxythreonine-4-phosph... 271 2e-71 1 21.3% 3:387 5:369 --KHLIIADDFTGANDTGVQLKKNGFQTEVML-FPTGDTIDH--AIVLDTESRTIPATAAFEKVATLTSkmEQNQFDLVYKKV----DSTIRGNIAEEIHAVADKYQPDLIVVAPALPTAGRTTVNGVQMLNGKPLMQTDIANDPLNPLWTDDIVKMLKKEFGSEVAL------------AKTDTNDLSPRSSKVLVFDAITDEDLTVIAksLKKRILYVGSAGLAGAL-------------FQKSRIAKPSLAVVGSISETSLKQMAYAVDAGTAIITVQINDMLKPDRKALITKYQAMVRSKLkgKNTVLTVTRRKEDYQKTIDAfdRSEISRIVRENLAAIASGIVkeSISGLFLTGGDTAIEMIRSLNASGSEIQSEIMPGVV-
56 UniRef50_B5XMU0 Sorbitol phosphotransferase... 270 5e-71 1 23.3% 3:384 129:529 --KLGIVADDLTGATTVGVLLARSGLKTAAFFDTEssRNEVEYPAMVVSSDSRPLPKAEAQHKVSAAVKQLQARGAHYFTK----RIDTTLRGGIGFEIDAMLEQlqETVAVVVPAMPQSRRILVGGYSVIDSVALSRTDVARDVRTPVTESWVPGLLAAQTHHQVGHIALTSVMKGEGQIQQDLQEQQQRGVRVIVVDAITVDDVDAIAGAVVALNwlAVDPglAVRRGLMREARSSAPASLTADGQRGSILIVAGSATPVTKKQLQYLIadDRVCHIPVDAELLVDRKNAAEIEVNRVVQHArqHNALFVFESALTGRLLNLQEelAHGEAAQNINHGLGSIVREvaSGEIKGLYMTGGDTMVNVLKELGATGIEMIDYVIP----
57 UniRef50_A8RYF0 Putative uncharacterized pr... 269 1e-70 1 19.2% 1:386 1:406 MM-IGAVTDDFTGAASAGALIARSQARTGLFLDAEALEDSEEadAVFVSSNSRHLKPEDAYREVCKATKALKSTGVTCFSKK----IDTTLRGRIGNEIDAMLDTLGGdvAVMVPAMPQSRRICLNGISIIDGTVLTETPIAQDVKTPVKDAFIPRLIQGQSRRKVELISIENVDRGKGTLKCAMIDARERGGQILVMDAVTLEHIDLIAQTCVELGwlAVDPGAfnYRRGMIKEEVSTGAEGSTGPEEKVALFVVGSANPLTKAQMKYLCSSEANVPVHVSAYMLISGQVQFEEEVNRAvrQKPRPQSIIIGTALQDCVveDLRRGYDSGTCSRLINEGLAEITGRVMeeQVAGLLLTGGDTMESVCRRLHVSYIEAIDHIVPQV--
58 UniRef50_D2LTG8 Type III effector Hrp-depen... 268 2e-70 1 21.0% 2:386 1:385 -MKIGVIADDLTGANGTGVRLTQFGFSSATIVKDAQIPTREHFEALILDTDSRYCERTIAKQRVEEKMELLANWEATL----YSKRIDSTLRGNIGVELDTMLDKHGKdvAIVVPAFPDSRRIVKEDILYVNNIPLHKTGVAQDPLHPITQSHVSTLLSQQTVNSVASIPLYD---NVDQLKQGLVRLFYQGKKVITCDAVSNNDITRIAKAMaeFNIISVDPG---PLTAQYAYETRNL-----QSEKHQLLVTIGSSTKTSSEQLSYLLNKTDAHPIYVDPNNLVGSKIAWKREVNTAILQalQEHSLILVTTHGQDHEvaKEQKVSVTTLAKQITDALAHISYSLLCNefKGVFTSGGDVTASLCSISSASGIELIDEVLPLA--
59 UniRef50_C2BZG8 Inner membrane protein n=1 ... 268 2e-70 1 19.1% 1:387 1:368 MKRFLIIADDFTGANDTGVQLSKRGISTKVFLKTLT---NQTADSYVIDTESRNMPSETAYSHLEKIIAPIDFEPFDFVIKKV----DSTLRGNILEELQAVDAAYQSELILFMPALPDLGRTTVEQIHYINGQRLLDTEIANDPVKPVTTDNIQTLLQNAfdETVHALSLDAISADAEVF---------QNGRLWAVDAQTNHDMQTiaLQTQKKILWVGSAGIADNL-------------MALEMPTAPALALVGSVSEVTKKQIQYAEKHnaVIQVPIHEILLHKNRSQYAAKIAQSLAA---GKDTIVLSSagKTMETCAKLGIKPEDVNFTVQSILGDITRrmQDQQIAGIFLTGGDTAIGFLDQLACSTVEILEEVLIGIP-
60 UniRef50_C6Y120 Type III effector Hrp-depen... 268 2e-70 1 24.7% 4:387 11:431 ---MAFYGDDFTGSTDALEFLSRSGIKTVLFIETPSAAQLARYpaIGIAGMSRTMSPAEMEVELQPAFKALAGLNPRHVHYKVCSTFDSSPagSIGKAIDIGAAVFNTKTVPLLVAAPILGRYCLFGNLFAryRLDRHPSMSRHPVTPAEESDLRLHLGKQTTKNIGLFDILALHQ----YQQESTALKLEGEDIVLFDALQQEDLKSIGAIigQTLFSAGSSGIEMALGAHWQENGTLNKEveDSSQHGPVLIASGSCSPVTAAQIAYALKNGfaEDLNADSILITEAAEKYALQATELIRQ---GKHPLIHTSLGNDDQRVneKNFGKAATAQLYGSLLGMIARKTAErkLKRVVIAGGDTSSYAARAMGIAAVEMIAPLSPGAP-
61 UniRef50_Q317G7 Putative uncharacterized pr... 268 2e-70 1 22.7% 1:387 1:389 MTRYAVIADDLTGAGDTGVQFAKAGLRTRILTHNWSAEDLNGVDVAVVQTESRAMPPQEAYAAVKQAAQRLQAAGVQPLYKKV----DSTLRGQIGPEIDAVMDVWGLELALLCPAFPENGRTLIGGYLLAGGEPVSRTSIGADPVSPVRQSHIPSLLAAQSSRPAIGLSLAEMTRG-DSYLESIFTEARRRSAIIVADAADPQdlESLVARFAPRALFVGSAGLAAPVAARLAQSSAGRR---------PVVTVVGSVNPVSRGQLKQLQHEGTGLLLVTADELLLDDRhtALRAKAETLAAMLRRGEDVAVATPGNREEvgLERRPLTARVAARTTQVVHEALALLQdeKPSGLVLTGGDMAHAMLAHLNTAGMDLIAEVSPGIP-
62 UniRef50_Q5WAJ7 Putative uncharacterized pr... 268 3e-70 1 22.4% 4:387 6:407 ---LGFYGDDFTGSTDAMEALDQYGLKTILFLRIPDQGMLKRfdCIGVAGTARAKGKAGMKEELEPVFSFLRDLHPFFVHYKVCSTFDSSPegSIGFASDLARRYFEKGSYPLLVAAPNLGRYTVFGHHFAAfrLDTHPVMARHPVTPMDEADLAKHLQKQTKQKIANVTILDL----EAKSASEIVKGESEAGLIVYDALNRGHMEKVSEVLWeaQFVVGSSGVEYALGEAMKREKQTQrrLKKPSQAERIFAVSGSVSDVTKSQLLAAEAAGFHAIQIPVELFTDEAKAEAF--LADVAAMIAAKQKVVIYTAKGADDPVIveSGVAKDEIGIFIGEKLGAWTKSILDrdVRRVIISGGDTSGFVTSNLDIYGLEVLDSVAPGAP-
63 UniRef50_Q652S1 Os06g0258900 protein n=6 Ta... 267 4e-70 1 16.4% 4:387 658:1058 ---LVVLDDDPTGTQTVH--------DIEVLTEWPVEALAEQFqcFFILTNSRSMTAEKATLLVKDICRNLEAAavPGVSYTVVLRGDSTLRGHFPEEADAVVSVLGedAWIICPFFLQGGRYTIDDIHYVAdiPAGETEFAKDAAFGYKSSNLRQWVEEKTKGrvSTISVNLLRkgPNAVCQHLCSLKKGSACIV--NAASERDMSVFAAGMIQAEL-KGKRFLCRTAASFVSARIAIKPKPPIRPTdtGGLIVVGSYVPKTTKQVDELRSQCeeVSVEMISMKSAEDRDHEISRVIELGNAYIQSRKDTLVVTSRQLITGKTPEE--SLEINYKVSSALVEIVRGI-GSRPRYILAKGGITSSDltKALEARRAKVMGQALAGVP-
64 UniRef50_Q65VM1 Putative uncharacterized pr... 267 5e-70 1 22.1% 1:384 1:406 MPVIGVVADDLTGATTTGVLLARSGSKTTVCFNTEAanAEVPSDSLLISTSSRPLLKHEAYKHVKEATQVLKNMGVQYFTK----RIDTTMRGGVGVEIDAMLDTLPetIAVVVPAMPQSRRILVGGYSVIDGVALTNTPVARDVRTPVREGYIPALLASQTRRKVGLVSLTDVMHGVYEIRIALMDQITQGKQVIVVDAITLEDVSNIAQamLDNPILAVDPgfTAALggLIHREEPNIPQTDATCAEDkvLVVAGSATPVTKLQMDTLCQDPRNISISVDPVLLIEgkDYMANDVRPRAILLETALHGPLLNLDAEDAKRKFVRGESAERINAGLGMIVSDIFKQIGHQRFAGIFATGGDTMVNVCNQLNVSAIEMIDYVIP----
65 UniRef50_C6DEB6 Type III effector Hrp-depen... 264 3e-69 1 23.1% 3:387 10:402 --QVLVVADDFTGANDAGVGLAQHGARVSVVFDVNKLHADLLGDAVVINTDSRAARDDVASQRTAEAVAAWQAAGGQGWIIK---KIDSTLRGNLGAEIAAALSAAEVPVALIAAASPMLGRVTCKGEVWVNGRLLTDTEFASDPKTPVTSASIAARLAEQTALPMAEIHLDDVRQ--ANLAHRLQQLADEGVRLIILDTDVQDDLEKiaSALPFRPLLVGSAGLSEALA---------NAQDFTRKTAKPLLAIVGSMSDIAQKQiaKLLSNVTLVEIDINALFSPHSSTVMASQCEEAVTALLNGHHCIIRTCHNENQRFEIDArlSRQQLGETISHYLGELTRNLvqRELGGLYLSGGDIAIAVATALGATGFQIKGQIASCVP-
66 UniRef50_B6W9J4 Putative uncharacterized pr... 264 3e-69 1 17.1% 1:386 1:386 MKEVMIIADDLTGANANCALMKGIGLTTASITGNDISDLRGEIDVFAFTTDSRAMSSAQAYKRVFEKVNKFKKDEV----ILYSKRIDSTLRGNLGSELKAYQDALGdrLAICVPSFPDSKRIVVNDFMYVDGIPLMNTDAGKDSKISAVSNLVTENFKKDYEGKIKHISINDIEKGIENIKKLIIEN--KDYDLLIFDAITNEQIRKIAKASIESKVN----FISVDPGPFTKEVTKILYKQSHIST--KALAVIGSVTNVTINQMKQLYknSFKLEVDPIKLIDIDLALEEIERATNLAEKELKERKLVVITTTPDDIEKRLdkKMSIDDLSLMISRGLAKIAKKIidKAISGAFTSGGDVTIAVTEELGSQGIEIREEIEPLV--
67 UniRef50_D1H3L1 Whole genome shotgun sequen... 264 5e-69 1 13.7% 1:387 787:1190 LKTLIVLDDDPTGTQTVH--------DIEVLTEWNVEPLVEQFrcFFILTNSRALTPEKATALIKDICTNIRNAavGNIDYTVVLRGDSTLRGHFPEEANAAVSVLGedAWIICPFFLQGGRYTIDDIHYVAdvPAGDTEFAKDASFGYKSSNLREWVEEKTIGrvTSISIQLLrgGPDAVCMHLCSLQKGSTCIV--NAASERDMAVFAAGMIQAelCRTAASFVSARIGIIPKAPILPKDLGINKERNGGLIVVGSYVPKTTKQVEELKLQCgsIEISVDKLAMKSSEEREEEISRAAEMalRASKDTLIMTSRELITGKSPSESL---EINFKVSSALVEIVRRIT-TRPRYILAKGGITSSDltKALEARRAKVVGQALAGVP-
68 UniRef50_C5Z818 Putative uncharacterized pr... 264 6e-69 1 16.9% 4:387 661:1061 ---LVVLDDDPTGTQTVH--------DIEVLTEWPVEALVEQftCFFILTNSRSMTADKAMLLVQTICRNLEAAavPGVSYTVVLRGDSTLRGHFPEEADAAVSVLGedAWIICPFFLQGGRYTINDVHYVAdiPAGETEFAKDAAFGYKSSNLRQWVEEKTRGRVSeiSITLLrqGPTAVCEHLCSLAKGSVCIV--NAASDRDMAVFASGMIQAEL-KGKRFLCRTAASFVSARIGIKPKPPICPNdtGGLIIVGSYVPKTTKQVDELRSQCgeVSVEMVSMKSMEDRDQEISRIVELGNAYIQSRKDTLVLTSRQLITGKTPEE--SLEINYKVSSALVEIVRRI-DSKPHYIIAKGGITSSDitKALEAKRAKVMGQALAGVP-
69 UniRef50_C1YLU9 Uncharacterized conserved p... 259 8e-68 1 22.6% 1:385 1:391 MAQVLVVADELTGANATGARFARTGMRVATVTPEHVSRVVGDYDVVVANLDSRHVPPEHAADLVTDVVEAVWPVGL------VVKRTDSTLRGNIGAELEATYDAVRERvvLFVPAFPSSGRITEDGLQFLNGVPLERTELADDPLCPMTTSSVADILAVQTDLPVRHVPVRQVTQTMLT-----AELLAGDEPVVVCDASTEQHLTDIAEAAAAAHHDTGIVWLAADPGPTGALLAYALRLRGQAGSRGPLLGVVGSTTELTRRQLATVARTGAVRFVDLDAvrADEVAEQTARELSEQLTSSGFPELCVLRVVTPSDRVRELPVQVRAerIARLVADVVNEVADTTGAHapSGLYLTGGDLVASLLDELDVHAFDVGGEIVPL---
70 UniRef50_UPI0001C35EE6 hypothetical protein ChatD1... 259 1e-67 1 17.1% 3:387 5:407 --KIIVLDDDPTGIQTVHGVCVYTNWSEESI----RAGFEEENPMFFILTNSRGFTAEETRSVHQLIGRRikISKEQKVPFVLISRGDSTLRGHYPLETETLRETLEAEGiiLCPFFPEGGRYTVGDVHYVAeiPAGETEFAKDRTFGYKSSDLKEWIEEKSGGrvLSVSVAELR-GKTLKGTEEKLLSLTGFQKLIVNAVEYRDVERFAEVCKACiiFRTAAAFPKVLGGITDQKLLGKEELVEQDNPHGGLIIAGSHVTKTTRQLEELKKDERIRFIEFNVALVTDerREQERVIRETDEALAAGVTAAVYTSRKRLDL-DTGNREDDLRLSVKISDAVTGIVPALSVRP-SFLIAKGGITSSDitKGLRVKKAMVAGQILPGIP-
71 UniRef50_C6JJI1 Putative uncharacterized pr... 259 1e-67 1 20.7% 1:387 1:384 MIKLVIIADDLTGALDTGVQFSKKNISTIVtlNFNTEEISKDADVIVIDTESRHISAVEAKKRVKSVLSKFDKKKIKFFYKKT----DSTLRGNIGSEIEGFMEGLDINEVSFIPAFPLSKRTVKDGILYVNDVKLSETQFAMDILNPVTDSFIPNIINKQSNINVE----------IKDINTDFPSKIDKEKNIYIFDSQNMEDMENIGKILYdlNYTIGNAGFAEILTHYIKTDTKK---EDIILEDNKVLFVCGSVNITSLKQCKYAEKTGYCSDTLNFNDIILENYKNSDNYINTKEYFKEKINNnlLKTSDSEDVIKKakNSISMENLTSNIANSTGQLVSDLieQNIRNMIVFGGDTLIGILKNIECQYIIPVSEIFPGVV-
72 UniRef50_A8S2W8 Putative uncharacterized pr... 258 2e-67 1 21.6% 3:387 4:369 --RYLIIADDFTGANDTGVQLKRRGYPTEVLF---AGKPVDSQKSIVIDTESRNALPGHAYEIVRHSLEQVDFGQFRYIIKKV----DSTMRGNIAQEIKAVDDAFCPELVVFAPALPALGRTTMDGVQCLNGVEICKTELSKDPKNPVMEDNLVKLLGQVYEEPVLLKYLPDVRS---------QSFSLDGGRIFVCDAESDDDLKRIIAAVRqrALYVGTAGMADNM-------------MELEKPTLPSFGVVASISSVANEQMHYCERAGYavKVPVAQLMTGTARPEEYRDMA-VEYLKSGRDTILLTDTAYDRELIELSQEVGetEVGDYVRSLIGRMAKEVLDseVSGVYLTGGDTALGMLMNIGADGSEILAEILVGVP-
73 UniRef50_B1B884 Putative uncharacterized pr... 258 3e-67 1 16.3% 1:387 1:364 MKKFLIIADDFTGANDTGVQLRRRGMDIEVLLDLNKDEELKAS--YVLDTESRNVKEEEAFIRTKDKLNSIFKNNFDVVYKK----IDSTLRGNIIPELIAMDEEYKPDIIIFAPAFPDINRTTISRIHMLNNIRITETEISKDLYKPVLEDDIYKLLRKGFDERVVHYGLNDIRNDNVRLVQGF---------VYTFDIENNEDLQEVVliSGKKVLWVGSAGMLDFICEIIKPFL-------------PSLGVIGSVNEVSMEQLKYCESKGtiIKIDIENFYSKR------HKYIERAIQILNEKKDVIITTSCNKEdiGQEKGFTKEKVGKYVQNILSELSEEIIktRISGIFITGGDTAIGFINKINAVGSIIIGEMEIGVP-
74 UniRef50_B4AJV4 Ketose-bisphosphate aldolas... 256 1e-66 1 17.1% 3:387 33:436 --KVIVLDDDPTGIQTVHSVSVFTDWSEESI----EAGFLEDSRMFFILTNSRSMTEKETTAVHETIASTIVKVAERVDqfIIVSRGDSTLRGHFPLETEVLRTTiqFDGEILLPFFQEGGRLTINNIHYVQeiPAGETEFARDRTFGFQSSHLGEWIEEKSDGstTYISLDDLRarIDQIKKQLMSVT--DFKKVVVNAVDYDDVKVFVTALIKAimFRSAAALTKVLGGIEDRALLTRHDLIQEQSPHGGLIMIGSHVKKTTDQLKALQQNKEVAFIEFNtvLEPELFHQEIDRVIQQTEALLASGQSVAVYTRRERLDLGDDRQEEELKLSVKISDAVTSIVQRLTIRP-KYLIAKGGITSSDitRGLHVKRATVAGQIRPGIP-
75 UniRef50_UPI000023E101 hypothetical protein FG0180... 254 3e-66 1 14.8% 2:387 42:447 -PVLVILDDDPTGTQTCHDVTILTVWDVPTVVSAFKQ--LGNSSGFFILTNSRALHPPQARDLMVEICTNLKAASQEvlPYEIVLRGDSILRGHFPLEPEAVEHVNGadAWILCPFFLQGGRYTISDIHYVHeiPAADTPFAKDATFGYKSSNLRDYVVEKSKGQIPhiDLETIrgGPDAVFQKIMGLPKRDKavLVINAAADEDMDVVITALLKAsyRTGAAFVSSRLG--ISSIPPLSASQLGLSKEVGGLIIAGSYVPKTTAQLDSLVTKSGviTLNVKALlsDESAKQDVSNAIELASQKIKNGQDVLVMTSRELIVGK--DEVESLDIGSTIAKALVSFLQNL-EQKPRYIIAKGGITSSDmtKGLRMKRALIVGQAAPGVP-
76 UniRef50_A7IJG6 Type III effector Hrp-depen... 253 6e-66 1 24.2% 4:387 17:423 ---LAYYGDDFTGSTDALEAITAAGVPSVLFLRLPTDEMLARFpcVGLAGSSRGRAPAWMDAELPAVFARLKSLGAPILHYKVCSTFDSAPhgSIGRAVDLGVGAMGGRWSPMVVGVPRLGRFQVFGTLFVtyRLDRHPTMSRHPVTPMDEADLGRHLARQTARRIDLIDMAQIRA--DAADTRRAMLEGDDTPVVLIDVMDEDTLTEAGRLIWENrfSASSSGLQYALAAHWRRLGLLPAQPGLPAAAgqIAVVSGSCSPVTAAQIGWARAHGftERLDLSRALDPTLREAEIARTLEVARAAlrGESPVIYSAEGPDDPHVLAfgLTRAEAARTVGTVLAEIMRRMVEArvRRIMVAGGDSSGEVMEALNAFALDIASGLAPGAP-
77 UniRef50_UPI0001C34ECE hypothetical protein ClM62_... 252 2e-65 1 17.9% 3:387 12:415 --KIAVLDDDPTGIQTVHDVYVYTDWEISTL----REAFKDSSCLFYILTNSRSFGKKQTEEVHRTIARRLLasGETNIPFLVILRGDSTLRGHYLLEPEVMEQvlKTDGEILCPAFFEGGRCTKDDIHYvngtEAAKTEYARDRTFGYRSSNLREFIEEKTGGRVksVSTQLLESGTEDCRLDELLKSAKDGQKIVVNAVCYSQLERFsrAVKQGKWFTVRSglVKAISGIKAKPFLTGRELLKKGTKSGGLIIAGSHVERTTRQLAELesIHPYCFIeaDAALRDGELRKEIQEVRKRAEQAISWGRDAVVYTSRRVLCRE--EGEESLNLSVRISEALTSVVRELSVSP-SYIIAKGGITSSDvtRGLGVKKALALGQAAPGVP-
78 UniRef50_A6TJU3 Type III effector Hrp-depen... 251 4e-65 1 20.6% 4:387 2:381 ---IYIISDDLTGANDTGIQYTKQGFRTLVTVKTDVetTSKSYDVISINVDTRSKLPDDAYHTVYDLVKKFENTGVDYIYKK----IDSIVRGNPGVELDAVMDASNAKIALVATSFPEVGRKLMNGKLELIDWEGNKSVI-----------DVIELFTDDMKRKVRGINLSTVKEGISSIVEVVERGTSEGVEVFVIDAESDEDLAViaTSLKVPPVLCGSAGLAKQLSLSGREIFNKKSNEVTQIEDKATLILIGSRNNITSQQLKVLEEE---MRIPVLTLMTGEVLNGGREAIIENTRGEVSSLIdiVVDTLFQGFTVQLKDSEAALMDSNYIAHAIGELAKLIYEtsIDTIVSSGGDTSQKLLDALNAKGIHLESEILSGIP-
79 UniRef50_B6HLA1 Pc21g12150 protein n=18 Tax... 249 1e-64 1 18.1% 1:387 34:438 LPVLVVLDDDPTGTQTC------HGINVLTVWDEEIleFQQCNRDFFILTNSRALPTPEARGLIREICTAVKHAAAkqRAFEIVLRGDSTLRGHFPDEPEAAEDVIGadGWILAPFFRQGGRLTIDDVHYVAdiPAAQTPFAKDATFGYANSNLRKYVVEKSGgrVHSISLEDIrgGPEAVSKKLLSLRKRS--VIVVNAVVDTDMEVFVLGLLAAkyRTGAAFVSTRLgaQIPPLIPKSLGLSTHASQPGGLILAGSYVPKTTEQLQSLIdrGPSLEVIVLklKSPEDADRAALDTADKAGQLILSGRDVLVMTSR--DLITGKDGVSSLKIGSTVA-AVLVLFLRLLVPRPRYITAKGGITSsaACKGLRMRRAHILGQAASGVP-
80 UniRef50_C3MI87 Putative uncharacterized pr... 249 2e-64 1 21.2% 2:378 6:397 -PLVGFYGDDFTGSSENLAQFHRNGLRTRLYLRVPSQETLAEadVVGFAGTARALDNSQITAEVFPAFKALGALGCTFLQYKICSTFDSAPqgNFGFAAEQLAGGGGEYDLVVLAATPDFGRYTAFGNHYAKfrLDRHPSMSNHPRTPMKESDLRRHLADLCSLDFTNIFLPEIRD-EATLSKRLENLLANRKG-VVFDGVDNRDLDNIASALWepVFAIAAQGLAQALGKQLAKHKNPLDLLDVGTTIAPalVLSGSCAIQTGRQIDAAVQAGwaLELNPLELTDGRAVARKIELVKPQIMAHLANERpiVYTARGHAMDRDRFEDIPPQLIGEAYANLM---VAARRETDVQRVVLAGGDSSSYAVRQSAAESLTI----------
81 UniRef50_C6WCZ4 Type III effector Hrp-depen... 247 3e-64 1 38.6% 4:386 2:374 ---LGAIADDFTGATDLAIMLRRNGHRVAVAIEDHdeRVRAGLDALVIALKSRTAPVAEAVAATRAAHERLLDWGARRVYVKYCSTFDSTDEGNIGPVLDAVADRAGAERVVVVPSLPANGRTVHEGLLHVNGQLLEHSPLRHHPLTPMTRSRVADLLRPQTRHEVAELHLDVVRSGRDALRAALDATAA---RYVVVDAVDDADLAVIGAAVAGDAVVSGGSGLALGLPDPHGDTDGW-----TAPASGRRAVLCGSASTATRRQVADAAGRAQPV-LRVDPVAAVRTPDLEVDRIAAWAVQQPADSTPVIHTTADAADLV---PEVDGLPAAPAVETVLAGVARRLVVSGVRHLLVAGGETSGAVVRALGVGVLRVGPEIAPGI--
82 UniRef50_A2C542 Uncharacterized protein con... 246 8e-64 1 18.2% 2:385 1:411 -MKIIIFDDDPTGSQTV------YGCPLLLNWDEQNLefKQSSPLIFILANTRSLSSVLAAKKTREICSSIKKFFVRQGYSkyISRGDSTLRGHGVLEPAILAEELGpdATFHIPAFLEGGRTTENGIHYLNGIPVHTTDFGHDNIFGFSTSNLAKWIEEKSFGKIKAKNILHVkdGFESLLKFLSKL--ENNTSVVVDAKLPHHLEILASAIkkRFLFRTAASFIKSLSAlcTADLVSLKSKNNEYKYKPGLIIVGSHVKLATDQLEVLMMDNSCKGLEIpnIFALEDRKQAILEIEYTLLSKIdeKVPVLYTSREERKFSSYSERMT---FGLELAEFMSILVRKIT-NKLGYIISKGGITTQILlkGFNFNHVHLKGQILPG---
83 UniRef50_A9BXJ6 Type III effector Hrp-depen... 246 1e-63 1 23.3% 2:387 1:425 -MKLAFYGDDFTGSTDALEVLAFAGLNCALFLDVPDEQTLAEfdAIGVAGASRAMSPTEMDAQLAPVLAAMSRLPVPLVHYKVCSTFDSSPagSIGRVMDLSRTAFGDTAIPIVAANPALGRYCAFGNLFArhRIDRHPIMSVHPVTPMHEADLARHLAGQTAMPVTGFTLPQLTLDRTEMAGELQRVvaTSGGAVLLDGTTTEHLTETGRLLDGLafCIGGSGLEYALTQWWHETGALPSIPTTHDrvPQVLAVSGSASPLSALQIDAAVDAGFvlPVDAAALVAASDPAAELARLvqALLALRAGHSVMLHSARGPKDPrgISREQARHEGGRLLGHRFGDLvaLLRAHPLKRLLLSGGDTSSHVTQRLAPQALRVVARLAPGAP-
84 UniRef50_A6VLH6 Putative uncharacterized pr... 245 2e-63 1 19.5% 3:387 5:377 --KLLVIADDLTGANDTGVMFAEAGFNTLLETNIHSLedIADAEIFSVSTDSRPI-AEKAKRKTKDTVLKGIEKGINRIYLK----IDSTMRGSVSHQIEGALAAWETLyaVICPAYPEMGRTIENGNLYVNGVPVNETASGKDAICPVTSSSMQDLLPEAICLAC------------SNSHELIKQINMVQNRQIVIDAKTEDDLSIIAdqLGNKIIPVGSAGLAQKL-----KLSAKGSVKKEKIDLGRALILVTSIHETSQNQVDQYISGVGGKSisPSQLINHELSGQA---LISQLTALIHSGDENVIIRANPAKVVNHTFG-NINEVARKIAEYLAEllYALNNEKFDSLILFGGDGAATLLEKMDISEMKVSYAVVPGVP-
85 UniRef50_Q7WNK3 Putative uncharacterized pr... 244 3e-63 1 26.5% 4:380 7:406 ---VCFYGDDFTGATAHLAGFHEAGLNALMFLRTPTLAQaaDEDVLGVAGISRSLAPAAMDQEIGPAFALFRALGARQAHYKICSTFDSSPrgSIGRAIEIGRACFGAAPVPVVPACPSFGRYVVFGNLYAqhRLDRHPAMSRHPATPMNEADLRRHLAGQTTLASALVDWRAVRAGGPALAEAWREAAAGDPGAVVFDTLEDADLDRIAAMLWEAsfCVAAQGLAEGLGRHMAQVTLARRrqAGIADAGPMLVLSGSAAPQNAVQIERALAAGwgIRVDMARALSETDRPGLAREVGEAMLAALRGGRSVvyTARGPDDPAIGqrGLGLSevAAVTGLLFAQWAraVQGAGLGRLVLAGGDTSSLAMRGLDAYALRIAA--------
86 UniRef50_A6W002 Type III effector Hrp-depen... 244 4e-63 1 23.4% 3:387 6:400 --ELAFYGDDFTGSTDVLESLSLRGKKTILLLRVPEKKDssDYDCVGVAGISRSKDPVWMKAELPKVYQFLNSFDPKYIHYKVCSTFDSNlkGNLAVATQVGIDVLSPSWTSIVVGTPKIKRYVCFGELFAdyRIDRHPVMSCHPATPMTEANLVKHMHQLGEVDCASVNLSMYSD--DSAATKLQQFIAEN-KVVIFDSVDHSSQAKVGALINelHFSVSSSGFEDA-----VYSQNKLVENINITSKSRILALSGSCSSITSSQIDYALSHGFivELDIARLLMLESRPQYLDEIVQTCIDLLSskSPLVYSALGPQKSGSTTaqDGDLHFDEMLGSFLGAIALAVTKTgiERLAVAGGDTSGYCIQSLNLDALTFIAPLCPGVP-
87 UniRef50_D1CHU6 Type III effector Hrp-depen... 244 4e-63 1 21.8% 2:387 1:340 -MWYAIVADDLTGAADSAARCLPSGLRARVSIG---GDASAWYDVEAFDTDTRHLPPAMASEIVAGVVEHCLRMGAVEVYKKV----DSVLRGNVGAELEAAMRAAGAELVLLCPAFPEQGRTVVESHLLVNDTPVTATSLGREVG---ASSYVPEILGAQTSLPVGLLGLRSVRSGREVIVQELEALRRSGARIVVADACSGEDLAAvaRALGRSCLLAGSAGLISVLAPHWARALPPP----------QVLVVVGSLHPTARAQVRLLLEKESCALVHTGNDEEPDDSS-----------------RVIVLLTPDEGTE------------GDHVGELAKRAAQVLRSRRVSGMVVTGGDSARAVLEAIGASGVALLGEVVPGLP-
88 UniRef50_Q67M11 Putative uncharacterized pr... 244 4e-63 1 23.8% 2:387 8:380 -PAIGVIADDLTGANATGVLLTRTGYPTASLTELrpEGGLDGYPCIVIATESRAVPADEARRRVADAARLLLDHGRRPMAK----RIDSTLRGNLGPEVEAVLEALGPgvAVLTGAFPASGRTARDGIHYVHGVPLAETEVRHDPLCPVTQSHVPTLVGSQTGLPVAHLPLAAVRAGAEAVARAIAEQARQGVRILCADAETDADIQALGQGMALSGVTCVAADPGPLTAAFVAASVP--------PVRGRVLVVAGSVTDLTRTQLDHLQAETGARLIQVDAGSLGRGGEDAEAEVRRAvlAAIPAGEPVIGVRSSEVLSVDPD-------AAGRIAAGFAEIAARALDrgVKGLYTSGGDITVAVCRRLQAGAIQLDAEVLPLAV-
89 UniRef50_A6X3H0 Type III effector Hrp-depen... 244 5e-63 1 20.6% 4:387 10:410 ---LSYYGDDLTGSTDVMEAMASNGVDTVLFMNVPDEELLSRFsaIGLAGTSRSETPEWMQENLTPAFKWLKSLNAAIAHYKVCSTFDSAPhgNIGKAVEIGKAIFDQAYVPLIVGAPQLKRYTSFGNLFAAyrIDRHPVMSRHPVTPMHEADLRVHLAKQTALKTVLADL--VALSAADANDRINAIVKDADGMLLLDVDSHESQLQAGEQLWRLrfVAGSSGVEYALLAAWAKAggAKKEFPLPGKADRIAVVSGSVSPTTERQICHATASGFtiDLNPLDLLGENGNQAIEAAIADGQKALQQGNSVILNTALGPSADRGTEIDKIAG-SRHKLARSLGLILRSLVErrLTRAVIAGGDTSSHALRELHVDALTTLLPltPGSP-
90 UniRef50_B9Y6N5 Putative uncharacterized pr... 242 2e-62 1 17.7% 2:386 9:408 -PKIVVLDDDPTGIQMVH--------DVAVYTSWEESalREEETMVFILTNTRALKPEAARRLLRECTQNLMAASKQtvPFWLVLRSDSTLRGHYPLESETVREVLQEQGiiLCP-YLQGMRITRDDLHYLKQepVGESEFAWDKTFGFHASDLKAYVEEKTQGrcLSISLEILRSQDEAAITRILR-QAHDFQKIIINAETDDDLRALmtVLKEKTFlrTAASFCKIYADQSEKPLMDPQACVQRKNQNGGLIVAGSHVQKTTRQLEVLRQNSCLETIIFDqqILQGTLAEESERCARLVNQKLAAGITVVLQTRRERVDLAQGSAEDQLRLTQAINDQFIRIVEQLTISP-RFMITKGGITSSdlTRGLRVRREWVLGQIELGI--
91 UniRef50_A9CVC6 Type III effector Hrp-depen... 240 8e-62 1 22.1% 2:386 12:422 -PLIAWYGDDFTGASAVMEVLAFAGLPSMLFLEAPTEEQLARFpgIGVASTARAQSPGWMATELPAVFAKLSRLKPLLVHYKVCSTLDSSPegSIGRAIEIGHDLFSPTTVPLLVAAPQMRRYQAFGHLFAgyRLDRHPVMSRHPVTPMNESDVARHVAKQsrLDVHCLSLEALAKRPGT-YPSLPSDGDDRITLITLDCMDASSESAAGHLIWNepFVVGSQGVTYALVRHWQESGLIPVAEAPegEAEPMVVVSGSVSPTTAEQIAWSKSNGFA-SIEFDAAAACGGTEAVEREIDraLNAIAANKDPLIHTAEGPDDpaVAHSAHDMSSANQMIGEALGRVLHtlLRTGTRRAVVSGGDTSGHATRQLGIFALTALAPTIPGA--
92 UniRef50_Q1QSJ7 Type III effector Hrp-depen... 240 8e-62 1 24.5% 1:380 1:394 MKQLlfYGDDFTGSTENLAQFCRHGLRGRLFfrEAILEMASELDVVGLAGTARGLAPSAMTEEVDPALALLDTLSPRLKQFKVCSTFDSSPtgSIGHVMDLARRRWPECALPILPATPAFGRYTAFSHLFTRyrLDQNPAMAYHPSTPMGEADLRRHLMAQTAIPPAAVTLLDYQQ-PDGGWQCLASAVEEQ-RFVVMDATQAAEIHHAAKLirHPTLAVAAQGLADALGGLVTRDMEQREPLPTtpGVDRLLVLSGSCSPQTRKQLAHMEAQGGCI-VAISPMEALRSPSALSERLAQEVMEAFTQSQTVGIATTFQDT--DLVDGLASDRLSLAVGEAYALLAQHlrETAIPRIVFAGGDTSSHAMRRIGADALELVA--------
93 UniRef50_Q31K87 Putative uncharacterized pr... 239 9e-62 1 21.6% 3:386 5:396 --KIIVLDDDPTGSQTVHS------CPLLLRWDVETLVTGLRHPSlfILANTRSLSTEAAAARTREICRNLQQaqLRLQHWLIISRGDSTLRGHFWTEPQAIAAELGPFQafLVPAFLEGGRITRQGWHLLrdRPLHETEFAQDPLFGYRTSYLPTFLATQAEDPSLSDRIPVLTA--DNLETAFTTASATSDRWFVVDAETPDQLQQFANRLKAAVLNHG-----HYLCRSAASLLSALAQLPLQPIAPqgVVVVGSWTTISTGQLEALLEQPQvvPIEPFVESDGRDRPPLAEDLDriQQALQQGQTPVIFTERQFHACASPEQQ---QQLSRAIADFLAERVCALPAE-IGYLICKGGITTNTILANLDAAIVELRGQIRTGV--
94 UniRef50_Q9LM23 T10O22.24 n=12 Tax=cellular... 236 8e-61 1 15.3% 2:387 686:1168 -KTLVVLDDDPTGTQTVH--------DVEVLTEWSVESISEQFrcFFILTNSRSLSPEKASELIKDICSNLCAAsvGNADYTIVLRGDSTLRGHFplEADAAVSILGedAWIICPFFLQGGRYTIDDVHYVAdvPAGETEFAKDASFGYKSSNLREWVEEKTAgsVQSISIQLLrgGPDAVCEFLCSLKKVNFsiVvvNAASERDMAVFAAGMIQAelCRTAASFVSALIGIIPKDPVLPKDFESNKESSGALIVVGSYVPKTTKQVEELQSQheVREVDVtaLKSSEVRDEEIRRAVEMADAFLRAGRETLIMSSRELITGKTSSE--SLDINSKVSSALVEVVSQI-STRPRYILAKGGITSSdaTKALKARRALVIGQALAGVP-
95 UniRef50_A8S9P3 Putative uncharacterized pr... 236 8e-61 1 22.2% 1:387 13:389 MLRLLMIADDFTGALDTGVQLAAHGIPTQVVVGQADLSACS-STVLVVDTETRHLPAAKAAKAVEELTRSAVENGVGCIYKKT----DSALRGNIGAELAALLKASGARNLPFLPAFPQIGRTTEKGVHYIKGVPVNESPFGIDPFEPVRCAEVTKLIHLQTE-----IPAQNLRPGETA---------ADKTGILVYDAATAADLETAGRQlgTPPVLAGCAGFAAFLPELLGLSDGSVVEPPQLDP--RLLVLCGSVNPITLRQMDTAEKAGFArrLTPRQKLEPgaSADGKAALAEIEQMLAANPRCIIETNDAGgaDYAAARGIDLDGMRVGISGSVGQMFGAlgSEHLGTLLLTGGDTLLQCMNSVGARELEPVCELESGIV-
96 UniRef50_Q7UTN5 Putative uncharacterized pr... 236 1e-60 1 17.9% 3:387 34:429 --KIVVLDDDPTGTQTV------YDTPVLTTWGVDELAAasPGTLFYILTNSRSLTEPDAIKLANEIGANLNEAALRTKQkvVVSRSDSTLRGHYPAEVTAIAAAVGTSDavIAPFFLQGGRYTIGDIHYVAevPAAETPFAQDAAFGFQNSDLKQWVIEKHDgqIASVSLNELrsDLSSLTDRLANLSPGSVCIV--NAACMRDMEAFVLAAQNAevYRTAASFVQAFAGLEPRELLTPDEMVDGNTKT-GLVVVGSYVPKTTQQLASLLENEssVVLDVDKLLA-DDSESYLLEVTQLVNESLQSSNVVLSSSR---KLVTGTDAASSLSIGNRVSDALVSVVRRLTKRP-RFLIAKGGITSSDvtKGLQAKHAMVLGQILPGVP-
97 UniRef50_B8GTM1 Type III effector Hrp-depen... 235 2e-60 1 20.8% 3:386 5:399 --KIIALDDDPTGSQTVHSCLLLTRWDVATL----RQALRDASPIFFVLTNTRGMDAHRAAQITREVCANLraAAGHPVNPVMVSRSDSTLRGHYPVETDVIAEAMGpdAHFLVPAFIEAGRITRDSVHYVVqvPAHETEFARDSVFAYRHSYLPDYVAEKTRGRIPAETVqtLADLRGDVTDRLMAL--EGNACAAVDAQTQADLERFADAVLTAalFRSAASLLTALARLPAQPVPAEAMSRYVRGGRPGAVIVGSHVKKTTQQLHRLLETPGTAGVEIDVNRLPGERDAVLRETLAAIQAIHERGDTPVVYTSRAE--RQFPDQQTRLAFGEQVSALLMDVVRGLPAD-IGYLISKGGITSNDTLsgLALATSRVLGQILTGC--
98 UniRef50_A6P1C4 Putative uncharacterized pr... 234 3e-60 1 18.1% 1:387 1:368 MNRYLIVADDFTGANDTGVQLKRRGVPTSVVFS---SEFIASEGSFVLDTESRALGPEEAAAAVRAGLKGVDLTAFGRVMKKV----DSTLRGSVAAEIKAVDELYGSELVVFAPALPDLGRTTVGGVHLLKGIPITRTELAKDPKTPVTEDNITRLLEAVYDEPVTHISEDQVSAGEIDFST---------GRVFTCDSATNADLrqAAVATGKRTLWVGTAAMADHLLGVEVDVPPALAVVASVSAVS-------------REQVNFAAGEgpLVSVPIPELLTGE---QKMETYVAQTVALLKEGKDAILASSASCNRAELDrnMTREQVSGYTQMVMGKMTKAILetPVSGMFLTGGDTALGFFMEARSLGSSIVTEIAVGIP-
99 UniRef50_A4FFA8 Putative membrane protein n... 234 4e-60 1 23.2% 1:388 1:371 MPQVLVIGDDLTGSNATGARFARAGLRTISVSGVERVPCAMEADVVVLNLGTRHAAAGVARERVRDAALA------APFADLVVKRVDTTLRGNVGAEVDALFEVLEPgrALVVPAFPDAGRTTVGGLHLVDGVPLAETFAARDPLNPVGSSRVATLLREGTRRSITEVPLDVVQAGAESVAEAL---SATDAELVVCDATTNAHLSTIADAAARVQDAGGPRWLSVDSGPFAVRLATALGIGPGVRALRPVLAVVGSITATTHDQVLETEQVLGARFVDVtdALDPTAIAERARELART------GIRIVGIRTVPPAQGAPADPA-----LAARIPGVLAEATAMLLDDGvgGLYATGGDIAEATTEALGSSGFAIDTEVLPLAVA
100 UniRef50_D1UTB0 4-hydroxythreonine-4-phosph... 233 7e-60 1 21.8% 3:387 10:396 --RLLIIGDDLSGTADCAVTCARHGLTSVVSFGPAPAMDAAQIDVLAIDTDTRRQLPADAARANQEA--WHAHSTGRRIYKK----IDSTLRGNVAAEVAALASVAG--MAVVAPAFPQAGRTTRGARQFVFGTPVEESEVWRNEGI-AGTADLQAMLGA-AGLRVATIDLAAVREGAASLQARLSACLVEQWQAVVCDSETDADLACIAAASadGVFWVGSAGLAAPLIEVLAARQSEpaRCGGTAHPRGVMTVVGSMSSVSHRQVALLRGEAglDLFDVDAADLLDPVSPAALMLTTRVTHSLMRGRHVIVAVSQSRRAAVDDGAHIARQLAERLAP---------AAAHAGALIATGGETARALLSAMKVNALRVIEEIETGVP-
101 UniRef50_Q6AB11 Conserved protein n=3 Tax=P... 231 2e-59 1 16.8% 1:388 1:378 MSEILVIGDDLTGTNATASAYARDGLRAVTMLDpaPVDLDDSIQVIACSTGSRHMTPARAAQTVDAIVRNF-----GYDVRAIVKRFDTTLRGNIGAEIEATLTATRAMhgLVVPGFPAAHRTTVGGYQLLDGEPILMGPASRDPFTPVRHSGVAGIIHEQTQLTTTNIGLDVVMGDTSTLADRLTRA-AQDAELVIVDSVTDDDQQRIATAASALE-SDERSWVVFESGPFGATYAHALGIRPHVDRANPILALIGSPTELTKLQSDRLESQSGV------DLITVDDPASDVSQLLSRLRASAEIGKTVIGIRTTSRDGSAPDPLHASQMLALII-DLAVECADSM---QFDGIYASGGDVAFAVLDALGARGYEVENEVVPLAVS
102 UniRef50_B9KXE4 YgbK domain protein n=1 Tax... 231 3e-59 1 25.0% 4:387 5:403 ---FAYIADDFTGATDVLEALASAGARARLYLDCAPSAVEPGLQAIGIATTARATAAAELPNVLAPLFDALVSLQPAIVQYKVCSTFDSSPegNIATVISTAWERFpqSVLPVIVGAPRLGRWVVFGNLFAryRLDRHPVMRFHPITPMEESDLGVILHHQGL--PHPVEYLTVLDYTLDQSTSFEKFQRTDRTVLIADTLLEEHLTTLGraLRTPALVIGSSGATQAICNALIERGkgEPLLAAPYPVDPVLVVSGSCSRVSANQTQRAIQAGFCEIAIVPDKLLHND--AYIEEVAEKIAQQLCRGKSVIAHTCSGPDDPRLLNRHSPWelGRELGRQLGELVARVAGrpVRRIIVTGGDTSGYVALAAGLKALDPIAVIAPGAP-
103 UniRef50_A2CCV1 Uncharacterized protein con... 230 9e-59 1 19.5% 2:385 19:436 -MKIVVLDDDPTGSQTVHGCLLLLRWDVDVL----RHGLRHPSPLLFVLANTRALAPAQAASRNREICSALraEGMSAAEVVVVSRGDSTLRGHGVLEPEVIAEELGpdATLHVPAFLEGGRTTVNGVHLLDGKPVHSSAFAKDRLFGYSTSDLPAWLEEKSGGQIRAQTVQRlkTGRTELRHWLARLHHNQS--VVVDAERSEQLLALAEAVRQLalFRSAASLLNALADLAPQPLAAdrRSDHSGQRWPGLVMVGSHVPLADAQLECLLEAPECMGVELpqILQMGLSDGRLAELEQHCFNQLGEALAIGRTPVLFTSRGELDCSTSAARLSFGVALAQLMARLAAALAplGYLISKGGITTHTLleGLGLEMVQLEGQILPG---
104 UniRef50_A5FXF2 Type III effector Hrp-depen... 229 2e-58 1 25.5% 4:387 9:415 ---IGFYGDDYTGSSAVMEVLGFAGVPTVLFLEPPDEAALadCRAVGIAGIARSQTPAWMDANLPGIFDTLARIGAPVTHYKVCSTFDSAPqgSIGRAIELGVPRLGGAWHPLLVAAPALGRYQAFGNLFAvhRLDRHPTMSRHPVTPMDEADLRRHLARQIAAPMGLVDLVALQGGRADAAL--AACLDAGERIVSLDAIDEATIAEAGRLIweRLFAIGSQGVEYALVAHWRrlLAPEAEPASAPPVKRIAVVSASCAPVTAAQIAQARRDGFTTFAVDAAAAADPALWARELDRAErlAALREGRSVVLHTAEGPDDPAIIRTRAAIAAAGEPAETIHARIGAGlaQSGLTRGVIAGGDTSGHAAQALGIGALTALAPLAPGAP-
105 UniRef50_B1X4P4 Putative uncharacterized pr... 228 2e-58 1 16.4% 3:385 5:419 --KIVIIDDDPTGSQTV------NDCPLLLRWdiLRVNLRGNYQFLFILANTRGMIASEAADTILKICQSIKQALLSESIKDWlsRGDSTLRGHFPLEIDSINTELGpqATFFVPSFLEGKRRTVNGVHLLNSLPVHKTPFACDHLFDFDTSFLPNFIEKKSH--CRLIASNIVQINVKLLNRAISnmSLTNNAFVTVDAESYEQLRVFSLLIKKVCfwNgaAGFIASLvqILPIYLSKLRRKSYTGKILPGLIVVGSYIPLADAQLDALLADPGCVGVELPIAKLINLIKqeRQWFQELQEILVMERTPVLFTSRGELTFDSSEERL---QFGYNLAQLMARLVSALA-PQLGYLISKGGITSHILleGLNLGWVYLDGQILPG---
106 UniRef50_C1YM77 Uncharacterized conserved p... 228 3e-58 1 20.4% 1:387 1:382 MAQILVLSDDLTGANATGARFAQTGMRVASVDAGHAAHAAPAYDAVVANLDSRHLPAHEAAGLVAATVDRLWPVDL------VVKRTDTTLRGNVGAELEAAWRAVRGrrVLFAPAHPASGRITVDGVQLLDGVPLERTQLALDPLNPVRTSVVADLVAEQSALAVRHLSL-----GRVTRADLVGELLAGDEPVVLCDAVTEDHLADIARAAAAASRGDGTVWVAADPGPFGALLARELGLRGTAPDPGPVLAVVGSATELTRRQLDTVAEDPSVEFVDVDatSDPGHRDEVARLLVGALTRSSFPAAVVVRTRASAEDVVRLPAEARRAMPGMLAALVAGAVAR----IRPSALFSSGGDVTSALLTALDVRALDVGGELVPLAV-
107 UniRef50_A2BYY0 Uncharacterized protein con... 226 1e-57 1 16.1% 2:386 1:409 -MKIIVIDDDPTGSQTVNNCLLLLKWDRNTLIK----GFKSKSNLFFILANTRSLSEKDAKLRLEDICNAIKSVICSERYKeiVSRGDSTLRGHNFLEPDVINDCLGpdATFHIPAFIEGKRFTIDGLHFVDNIPVSQTIFAKDKIFGFKTSNIKNLLFQKSKLQINLNDIQNLKSQELNILETNEnkNLKKNSHVIVDVENYSQLKKFSLAINKLilFRTAASFISSISGIkpFFYSNLRRRNREKKFLPGMIIVGSYVELSTIQLKQFlsDCELIELDVFEFYKIFASKQESAKLikIRCILKKGKTPVIFTSRKE---VSLDDNHQQINLYNSLANFISELVADL-KNEIGYLVSKGGITSNVIlnGLKANYVYLQGQIITGI--
108 UniRef50_Q1YDM8 Putative uncharacterized pr... 226 1e-57 1 23.4% 4:387 11:418 ---LAFYGDDFTGSTDAMEVTAFAGLRTVLFTRTPNARDLadYPVVGIAGTARSRSPEWMDQNLPGPFRALADLSPRILQYKVCSTFDSAAdgSIGRAIDIGDSLVAGPWSPSIVGAPQLGRWQVFANLFarYRIDRHPTMSRHPVTPMREADLRLHLAAQTERDIVAIDVAAIAGG--TADEAADRVRDKPGTIAFIDVADEMTQAEAGRLVWdpVFSASSSGLQYALVAHWHRAGmtPAPFAPVPPVDRLLVLSGSCSPVTAEQIEIAEASGftIRLDVVQAIAPETAATELARIETAVDAAIErgRVIVFAARTVDDPaaADRNISFSDAQDSIGRALGRIAATAVPrgLQRIVVAGGDTSGRVLEASPVTALEIAHPLGKGAP-
109 UniRef50_UPI00005102E2 type III effector Hrp-depen... 225 3e-57 1 20.9% 2:388 6:401 -PRILIVADDLTGGNACGALFAEAGLRTITVTgvNLDDLLDDYDAVVLNADSRHLPPEKAAELTESLI------GITSDIDLVACRIDTTLRGNVGPTAEAALRapGRVMGLCIPAFPASGRVTVGGRQLLNGRLLEDTELRNDVRSPMRTSVVADIVQENTDLQCHTVELSTVLAGHDAIRSDVIAAVAAGADVIVADALNNEHIDLVARAVVDIGREETIDWVCIDPGPG---SLALARVLLPPRKTGAIFGVSGSATEITRTQLAKLNEDPTITVVRadADDLPDVRATLERVRTAASARAGESQADAVRAVIVATVVDAADLLELTDEQSESIPRRLAQITAemASIAVTGLYTTGGDVTAAVLAELGALGMEIDREIVPLAVG
110 UniRef50_B2U6L2 4-hydroxythreonine-4-phosph... 224 4e-57 1 21.5% 2:387 9:381 -PKLLILADDLSGAADCAVAGVRAGLRSAVMLRADVGhyPTSADVLALDTDTRRANAVDAAATQVAAWHAL-ARPATRLYKK----IDSTLRGNVAAEV--AALAPLAGLAIVAPAFPAAGRTTRDGRQWLHGVAVEDTEVWRNESIGGR-ADLRVMLERQ-GLQTAVLTLDDIRAGAAALAGRLAALQADGVQAVVCDAQTDDDLAHIAETSVRlvFWVGSAGLAPAlaAGLGSANAAVEGDAATAIAGPVLTVVGSMSSVSHAQASELKAAAGARLLSLE--LPVEELDTPQADITQTVIDALCEGRDVLVTLSQTTRGNSADGLHFCRRLATLLAPAL---------PHAGGLIATGGETARAVLSTAGIDALRLCDEIESGMP-
111 UniRef50_C6Y0I7 Putative uncharacterized pr... 224 5e-57 1 20.4% 4:386 2:355 ---IAVIADDFTGAAEIGGIALRQGWNAIIDTRVQKGT---ETDILIIATNTRSKPPQEARKTIRELTLQLLSLSPEIIYKK----IDSVLRGNVGEELLEQMAVSQKRRALLIPANPSLKRVIKDGIYYYEGLPLKDSTFARNVKHQIGSSRVIDLMGDGAGKDTVVISRAELM---------------PDKGLIIGNTTDEADLDHWAGRVDEETIMAGGSSFFNALLRKIKVHPYT--DPAGFAFGKKVIYVCGSAFPLSRSVVEDARQAGQYVSYMPSRMfpAEKSAYMAHWEREILKGVQQSGTVIV-------AINVIEEPRVENLSSELGKTIATVIANVMQGVQLEELVIEGGATASAIIEKLEYRKFHPTQELAPGV--
112 UniRef50_A5GQ91 Putative uncharacterized pr... 224 6e-57 1 19.7% 2:367 71:418 -PKIIVFDDDPTGSQTV------RGCPLLLEFSTAnaGLADPSPLLFLLTNSRALEPEQVRQELTALCRRLKPLLAQlrPWLVVSRGDSTLRGHTPLELEVIRAELGPFAavLVPAFPQGGRTTRDGVHLLHGEPLHHSAFARDQRFGYPSSDLPQWLQHKTAGATPADCVARLKP-----ADSFAEL--ETGQWAVLDASTPNDLDVIGEQvgRKHLCQSAASLLNGLSEM---PSVLLEPGEVPPIAAPGLVLVGSHVPLSDAQLSSLLQQPGCCGVE----FSLDGTPELGALTAQVQRLLSAGLTPVLFSSRGERTGYSPARQ-------RELALQMAQVVMDL-EPPLGYVIAKGGTTSLTF---------------------
113 UniRef50_Q28MT1 Type III effector Hrp-depen... 221 3e-56 1 22.5% 2:387 4:394 -PRLAWYGDDFTGSAAVMDELAQAGLTAVLFTRMPDDATaaGYDAVGLAGTARTRGPAWMRRELPGVFDWMERTGADHLHYKICSTFDSSAegSIGLAAEIGLAQLG-GWAPCLTAAPSMGRWQCYGTLFARgrLDRHPVMRQHPSTPMAEADLARHLAEQTDLPIGLLTLDQLAGGVPE---------RDRDGIVLLDAQREADMVLAGAILAdaGLLLGSQGVEMALIAHWRAAGRLGSEQPRTprPARLAVVSGSVSEGTAAQITAAKAAGFATF----ALDTASLLDGAVPDLTKATAALRQGASILCHTALGPQDprQRSLGLSPEDTAERIGTALGQVLARLAPTA-ERLVVAGGDSSGFVTTALGVDALTALAPVDPGAP-
114 UniRef50_UPI0001B4C831 hypothetical protein ShygA5... 220 5e-56 1 21.5% 3:388 35:434 --RLVVLDDDPTGTQTVA------GVPVLTAWTVDDlaLRQDSTAFFVLTNTRSLAPDTAAARNREVVRALaaSAAEGVGYVLASRSDSTLRGHFPLETDVLAEETPVDGVVLVPAYIEAGRFTADSVHWMRtlPVGRSEFARDATFGYANSRLPEWIEEKTGGRVSaiTLEDLrrGPGHVARLLASL--RDGRMAVADALCDDDLRVLALAGATAevYRCGPSFVRARAGQGARAPLTPAEllGDGAAAHGLIAVGSHVGQTTRQLDRLRERGGifELDVHALLDEGRRATHIADVAAACAQALATSEVVVRTSRALVTGADADDSLAIARSVS--AALVATVRAVTAARRPAYVIAKGGITSSDvtEGMEIRRAWARGTLLPGIVS
115 UniRef50_C0VS62 Putative uncharacterized pr... 220 5e-56 1 16.2% 4:386 30:424 ---LIVLDDDPTGTQSVAD------LPVLTRWTAKDLefAQNAPAIYVMTNSRSLDPADAKQINIEVAEAALAAAGDRK-LTFVSRSDSTLRGHFPLEPDTLADVSGvdGYLIVPAFGDAGRITVGGVHYAGsvPAAETEFAKDATFGYIHSSLAEWVEEKTRGAKKADDVIVIDLDDLRGGTAQDKLraHDRQAIAVDIVSEDDLRLLAAALKKAeyRVGPPFVRAVIGQDIptPEKLRSAGVTTDHVKGGLIVVGSHVPTTTRQLNALIDANLATTTELNVKTVLEDAEGYTDRLALEISTALEKGNVILHTSR---ELVTGKNKDDSLRIARTVSEALVGTVNKVIHttPKFVIAKGGITSSDTakGLEMTRATVVGPMQPGI--
116 UniRef50_C5CVE2 Type III effector Hrp-depen... 220 7e-56 1 24.2% 2:386 7:407 -PAVVYYGDDFTGATDTLGTAARAGLRALLFLKTPDAARLAQadVLGIAGAARAMTPEAMQAELAPVAALFRSLGARVLHYKTCSTFDSAPhgSIGAAMRALRGAVEQPWTAIVGGQPNIGRHCLFGNLFAAarIDRHPTMSRHPVTPMHEADLRLHLAKQGLAGVRSIPFTAASQGPEALGEALQRALRPDAgaVLFDVADAPQLAAIGQVLWAEalAVGPSSVVDALAGALGTRSGAQapRRTGPARGPVLVLAGSLSPVTARQVAAARSF-DTVWLDAPRLAQ-RDAATLERHARDIAQGLARGRNVLACTRPANEAPTGADNEVDAQALSRAGGDLLARV---LAMAPLQRVGIAGGDTSSHAVQALDAWGLSYVADMGAGA--
117 UniRef50_Q1LK60 Type III effector Hrp-depen... 217 4e-55 1 21.8% 2:387 1:371 -MTWLIIADDLSGAADCAIGFAAHGARAVVTLDVADSVGIADAEIVAADVDSRRMTPEDATTSNIDAWHRGDGRH-RRLYKK----IDSTLRGNWAAETVALQPLAG--LAIIAPAFPATGRTTRGGRMFVNGQPLEDTDIWRLEGLN-GHADMVALLAAR-GLATALLPLDVVRAGAPAVLAELRARQADGIAAVVCDAETEQDLVTLADalDTPAYWVGSGGLARSL-STVAQVTRAETTSPVTYHQGPVLTMVGSMSGISGKQAAYLCERARMEALVVAPQTLRDGPGHPAWTTTRQSITNCLSAGRDLLLSIGRDDAFDPAE-------GPRLSTALAQLALP-SFEHVGGLIATGGETARAMLGAAGIAALALRHEVEPGVP-
118 UniRef50_Q9KEP7 BH0802 protein n=3 Tax=Baci... 216 9e-55 1 27.0% 2:257 1:248 -MRIGVIADDLTGANATGVRLVKQGFPAATVVHSASVPSGDNYQALIMDTDSRYVRSAIAAKRVTDAMNQLKRWGARMFTK----RIDSTLRGNIGVELDTMLAELGEsvAIVMPSFPDSGRTVTGGYLLVHGVPVQDTFVSKDPVSPIITSYVPDLLRKQTKHPVGYVGLHEVMSGRNVILQHVEQLISEGKRLIVIDAVTNEQVDDVAKaiKDRPIVPACPGPFTA--------AYVRAVTQQQQEDARLLVAVG-----------------------------------------------------------------------------------------------------------------------------------
119 UniRef50_C1YVK6 Uncharacterized conserved p... 216 1e-54 1 23.2% 4:387 1:349 ---MAVVADDLTGAGDTAVQFLRAGWSTELQLSPAPST----AEVVAVSTDSRALPAKRAAHAADETVRRLRGAGAARLYKKV----DSTLRGPIRAEIDATLAAWSPGaaVVCPAFPATGRTVRDGVLLVDGVEVHRTAVGRDPVTPVTESRIAVLLGA-----------EHVRLTGGDARADAELLRAAG-PVVVADAETEEDLDRLAaaLGPDAVPVGSAGLASRLARSWAEQEA----------PAPALVVVTSLHQTARGQVEELVADPRTRIEQPAP-----GDLADEEAWLSWTRGALERFDPSTAHTAL-VAPEDRDGQLDPAAVARRMGEFAAALAGR---HELSGFVVTGGDGARALTRALEARAIALTGEVAPGIP-
120 UniRef50_C4DF57 Uncharacterized conserved p... 214 4e-54 1 23.6% 4:388 7:389 ---ILVIADDLTGANATAAGFARAGLRAVTVggTVIAEFTNRFDAVVVCTDTRHAPPAEAAARVEAAIAAAPPV------RLVCNRVDSTLRGNLGASTAAVLRAVapTVALFLPAHPAAGRQTVEGNQLLDGVRLENTELARDPRTPLRTSDVADLLTQQAALRIAHIPLSLVTGDPVRLRKAVATRVAAGAQVIIGDALTVEHLRRVTDAAveVEWVGVDPG-------PGAVELARAKGLTGHDDTAPLLAVSGSATALTRQQLARLRETRPVTVVRpsGDTVLPDLEPTAKQLAAALAQADSGDTVLLATALDDGDIVDID----PADAARLPQLLAGAVRRALAERAVGGLFVTGGDVTAAMTAELGAAGIEVEQELVPLAVA
121 UniRef50_A4RGJ1 Putative uncharacterized pr... 212 1e-53 1 15.6% 2:359 43:424 -PILVALDDDPTGTQTC------NGIPVLAVWDPATLTAerPGSGFFILTNSRALHPPQARSLIREICSNLKAAAAEavSFEVVLRGDSTLRGHFPLECDVASEVLGedATLLCPFFLQGGRYTLGDVHYVAsvPAAQTPFARDATFGYANSDLREYVVEKSGgrVASLPLEDTRAADGVDRVLKRLLAVDRGSVVIVNAAAEEDVDVVVLALLRAafRTGAAFVSSRLG--ISPIPPISAQQLKFTKDAGGLVIAGSYVPKTTAQLEALVHKSgtVVLDVEKLLevTAEQGEVARAIEQAEKEITRGQDVLVMTSR--KLVVGKDAAKSLDIGSTVAAALVSFLVNL-KTRPRYVIAK-----------------------------
122 UniRef50_Q0FNR3 Putative uncharacterized pr... 210 6e-53 1 24.0% 3:386 4:367 --RIVFIGDDFTGASDSLATYERAGMRARMVLG---AAGNDGLEALGLPTDLRSLAPAPARDEIDRLWPRVAAEAPQVIHFKVCSTFDSAPegSIGAVTQALIDRFSPDVVAVIGGQPSLGRHCAFGTLFARgrIDRHPIMSRHPVTPMREADLRRHLAAQGLEGLALISVSDLRTPEDVAKTLRA-------GPALIDATHADDLPRIAEAlgGRQLLVGASSVAEILGAGTHREPSNAVLP---PASNNILLFAGSRSQTTATQVAEASSY---------AKLALTPEALRSGALIPPARELLSAGTPTLVHLLPEADYGLSPDALADQ--------CAAFVAALLDRAEVGHLGLAGGDTSSRICAQLGFDALAFEHTLAPGV--
123 UniRef50_C7MF44 Uncharacterized conserved p... 210 7e-53 1 17.2% 3:381 12:405 --RLLILDDDPTGSQCVA------GIDAAFDTDPaaETLAAPGSAAFVLTNTRALDEAEAVALNRRILAGVLEAGIPAQGLHVVSRSDSTLRGHVIAEPTAIADELAadAFVLCPAMLEAGRFTTGDVHYAraVEVAETDFARDATFGFTSSDLREFLAERSNGAIasLSLEDIRTGGPARVREIL-GSARDRRWVVVNATEYADMEVVARVIAELevTRCAPSFVRPLAGqgARVLGAADIPVPADRQEHGLVVVGSHVGLTTAQLHVVQERGTLLGVEIdpSVLDERREEHLAQLAARIREALPRTDCVLYTSR---ELVRSEDPAESLAIARRVSDAVVEVVQQVRTARPAWVVAKGGITSHEVAagLGIRRARVEGQ-------
124 UniRef50_D0DC39 Type III effector Hrp-depen... 210 8e-53 1 21.6% 3:386 4:368 --RIVFVGDDFTGASDSLATYTRGGLRTRMLMSPEAGT--SGLDVLGLPTDLRSLPPERARAEVARLWPRIAAEAPGVLHLKVCSTFDSAPhgSIGAVALALAERFAPDIVAVIGGQPSLGRYCVFGNLFARgrIDRHPVMSRHPVTPMGEADLALHLGRQGLEGLSKLGHAELADTAGCVARLRA-------GPMLCDAVSDTDLAQIGVALRAAglLIGASSVAEILGG---DASSTPPVPAPPPQSSGLLLFAGSRSAVTQAQVGRARAYRK-LPLTPEALASAEPVETAAR--------LLKDGIPVLAHLLPERDYGLSPDALAD--------RSCAFIAAVLARAEIGYLGLAGGDTSSRICSGLGFDTLDYESTLGAGV--
125 UniRef50_Q21SI3 Putative uncharacterized pr... 203 9e-51 1 20.1% 4:387 8:367 ---LFILADDLSGAADCAMGAAKSGLKSIVLFNP---AIAEQAQVIAIDADCRYRPAAEAGAINVALWQA-QATSERLFYKK----IDSTLRGNFAAEMAALTRA---GVAIVAPAFPATGRTTQNGRVFVKGVPLEQTEIWANESIP-GQADIVAMLRS-AGISATNITLPGVR---NKLRDEISRLVAGkvQAIVCDAEEEADLAAIAAavGLPVYWVGSAGLATHLPQ--AAGLVGQAASPRLAVSGPIVTVVGSLSAVSRQQAQVLESHafAVFVPTPALLRTGETHPLWQSLRDQIGEALSAGRDV--------MIRTGLEEHNDLTYGHALCESLGSLVLPLA-PAIGALIATGGETARALLPTFGTHALQLIKEVEPGVP-
126 UniRef50_C1B6A5 Putative uncharacterized pr... 202 2e-50 1 19.7% 3:387 21:425 --RVLVLDDDPTGSQTAA------GVPIATDFSPESMelREAAPTAFVLTNARALDENTTRELTRSIAQTATTVADrrLQLSIVSRSDSTLRGHFPVDVEVLTeaGTPRVLVLCPAYPAAGRITRHGRHLVRsvPVGETAYARDATFGFSASTLPDWVQERSHGrvTVVSVTDIRRGPDHVSRLiaTASGFDPGPVCVDAETEADLDVVAAALErrTVVRCGPSLARARGghSSRVSPERLRAALDPTTGpgLVVAGSHVELTTAQLRHllDRVSTVELSTADVVDAATRDAAIDRAVTECVSALAVSDVVLRTSRDVVVGVDEDDSLS---IAAAVAHALStaSAVVAAAPPRWVVAKGGITSADvtKVLRLRRAKVLGPILDGIV-
127 UniRef50_Q6W0X5 Putative inner membrane pro... 201 4e-50 1 20.6% 4:387 11:347 ---IGVVADDLTSAADGAIAFLERgiPRICRVGSDDTH----ASLVSIDTGSRTLDEADAAHVTRQAVTTLADR--PLLYK----TIDSTLRGHIRVEIAAAFQASGRPRLVIAPAFPAAGRTTIDGIQLLHGEPVAQTAYSRDPVHPARTSRIEDLIEP-SLGRIARISAHTEDGEIGNAI--------GDAPVVIVDACEQVMlrRIAEIQKHGplWVGSPGMAEALATVVERRTG-QDIFTPEVTPNRVLVLVGSANHVSRSQCERLAATGASVAMRATDL--------------DEAASVVCIRTPHIRTSDPAKALATLVDE--------------AEIA--LSRHRYDAIVATGGETMQALLERLTIHAFDLIRELEPGFP-
128 UniRef50_A0JRK3 Putative uncharacterized pr... 200 7e-50 1 19.2% 4:388 37:464 ---LVVLDDDPTGTQSVADLPVLTRWDVADfwAFAHIRDNQTKPAVYVLTNTRSLDAAEAAeiVRNALTAAGSAGSEalRLGFVSRSDSTLRGHYPLEPDVIAATVAadGVVIIPAFPDAGRVTIGGVHYMRgtPVAETEFAKDASFGFANSEMAKYVEEKSQGrvIVLDLNIIRASTdaIADAIES--ATESTPIVADIVSENDLRALSLGLEEAeyRVGPPFVRARIGQEiaELSGEEAYAGNTPSEAGGLIVVGSHVGVTTRQLKALTEQHSavEIDVEKLL-GDAAASYLDETVDMVVEALRGGDVIVHTSR---LLIRTDDAAESLRIARTVSAAVVAVvrTLKTFPPRFVIAKGGITSSDVAagLEIRHAIVRGPMLPGIVS
129 UniRef50_B8H6Z8 Type III effector Hrp-depen... 199 2e-49 1 21.7% 1:387 1:395 MPAFGFVADDLTGAADVLAQAHRYGLEAALVIG--DAPLPTDAAVVGFAGPARSLAGTAFDALVSRDLAGIAALNLDVLLYKVCSTFDSSPtgSIGRGIELLHEQFPLHGAivIPAQPGFGRYTAFSNHYasYRLDRHPVMSRHPSTPMSEADLREVLAEqsGTTPGAIHLPAYEDGTFK-DAWADRRHEPGAQAFVVDAVDEHHMDAVAEVLTrpSIVVGSGGIMAALARTLS--DSVPAAPGAQAASGPALAVSASASSTTAEQISDAVAHGWVEVPVPVELLDRHSPALVAALDERVSAALRAGNNVVVHTTRGAGDPR---YGTAKPVDAGYVGALIGGIAARIAQAGLTriAVFGGDTSSHALIAMGVRQLRVSGQFVTAGP-
130 UniRef50_A0QQW2 Putative uncharacterized pr... 196 1e-48 1 15.8% 2:386 1:376 -MKTVVLDDDPTGTQ------SASGVRVLlcSADAIEETLRDAESVYVQTNSRALAEADAVDLVRRIRADGEEAARRlvDVRFVLRGDSTLRGHVFAETEVFLD--GDAVMVFVPAFPDGGRTTRDGVHYVndLPAHESEYAADPVFGFSTGVLVDYVAEKSGRTAVPVPLATVRGGGLATVLS----TARPGTVVLPDAVDNTDIRVIAEAigRAIVVRTAAPVAAELAGVTSRGLL---RAPLLDRPLPTLLVCGSHTTGATTQLAPVI-DRWGAPIVVDTAGALDDPDSEGRHAADQLRAQLDARSFAVLMSE-----RDRSSDHNTLSHGERIMTALTTAVRGAL-PHLSVVVAKGGITSAEVArgIGATSALVLGQVCPGV--
131 UniRef50_UPI0001BC2D3A hypothetical protein BlinB_... 195 2e-48 1 21.9% 4:387 1:373 ---MVVVADDLTGATDSSVQFAYAGWKTQLLLSEDSVTHREPGAVSALVTDARALTRAEAQNRTRAAVLS-GHDAATRLYLK----IDSTMRGTISSQIDGALEAWQQdfALVCPAYPAMGRTVSDGQLLVNGTPVQDTVIGRDPVTPVSTSSLSELLPGSATVTKPHGETFTVAALVASIRTARAS-----SPIIIIDAGESADLDVIAEafGDDVVPVGSAGLAAALAVKWGTGLVAPAESDRTCE--RVIIVASSLHTVTREQVQALVDVEPPEVQATEVTVLTPDLTALSDEAAR-----SAWLETVSSTASTPIVIVDAPEERTSS--TDLVADLLAGAAATLMRDSvtSLMLLGGEGARAVLNRLGAVSLHIHSTVREGMP-
132 UniRef50_D0WL58 YgbK domain protein n=1 Tax... 195 3e-48 1 18.9% 2:388 42:450 -PVYVVLDDDPTGTQSVA------GLPVLTSWEVGDfaFETGAPAVYVMVNSRSLAPEDAERVNREAVAAALEAAEAGGADvfVSRSDSTLRGHFPLEPNTIAEClrADGIVVVPAFGDAGRITVHGTHYAGdrPVGETEFARDATFGYAASNLAEWVEEKTGGAVPalDIETLRTDLDGAVALLTS--ARDARPIVVDAVEEEDLRQLALALIRAE--RAGSRFIYRVGPPFVRARVGQAVHAPLTPEEIEASRAgsHVDLTTRQLAELRARRreLEIDVAKAVNPSSRGPHLAELIDAAAAGLKEGDVAVRTSRTLVTGADADDSLA---ISRKVSAAVVEAVKglARATPRFVVAKGGITSSDVakGLGIRRATVVGPMLPGIVS
133 UniRef50_Q20Y36 Putative uncharacterized pr... 194 3e-48 1 19.9% 5:386 6:373 ----LILADDLTGAADCAIAFGRRGRAAAVTWGEADAAQDHQLPVLAYDAASRGLSAADAARRHAEVLTQL-AAAERILFKK----IDSTLRGQPAAETAATlsRLGGAFGVFAPAFPATGRTTIDGRIVVGGQPLEQAEVwrDHSYP--TADLVDVLAS-AGVRGEKVTLAAIRGGE--LRAVFAKLSRQGDVVAVCDAETDQDLHLIADaaSPSTFFIGSGGLAHALAGLEAEHAVAPLRIPT--SAHGTLIVVGSLAGASRSAACKLVATGTVAHFPVTPQTLLNDGGGRAELALAVMQRLSGGGDALVEIVM---------NDHPDMALGPKLAQRLAETLQSVA-PSIGAFAATGGETAAALLARFGVNGIRLADEIEPGV--
134 UniRef50_UPI0001C31005 type III effector Hrp-depen... 194 4e-48 1 19.2% 4:388 2:405 ---LLVLDDDPTGSQTVA------GVPLLLRFDDADValDDGGDVVFALTNSRALPERDAVALTRSVTRSVASAaaRGRDVRVLSRGDSTLRGHFPAEVDALVAGLgpDAILLCPAYPEAGRVTIDGVHLLRdvPVAETEFARDPVFAYGESDLREWAARrsPSEVGHVALGEIRAGGAARVAELLR-DARGGRVVALDAETRADLDVLAAGIVAAE-RAGRRFVYRTAPSFVAARAGRAPAPPLHTLPAADVAvvGSHTDLTTRQLDAAVAAHgvVELSVAALVDPGLRAAELIRVAEAAQRALERGDVALATSR--EVVVGGSAAESAAVKGRIAAALVDAVVSIVSACVPRWVVAKGGITSHDvaAALEAGRATVLGQLFPGQVS
135 UniRef50_B1L711 Putative uncharacterized pr... 190 6e-47 1 19.7% 1:385 1:313 MMKVLIIADDLTGALDTTSKFGKG--------SVVSLRGEVSSDFVGISTDTRLLRPDEARLRVRDSLKRF--SGWHYLYKK----IDSTMRGNVGAEFDEICESSGVR-IPFTPAYPEQGRIVREGLIYVRGRLLEETDYVRE--LPKCSSDILEIVKATSRLRVG------YWYGEQDIMTFR-------------DVRDRSELSRAFRLIEESGFKvgSAGLAMELSNFLGCEKADYVEL-----YNPLLFISGSTNEVTLKQLERLSERIEV---------------------------LSDGSLDLARKNLMEGSSVAISFDLGSSL------SRIGKIAELLLDLRPGSLVIIGGETLRRLLDLLGASAIRIGSYPEEG---
136 UniRef50_B9KVC4 Putative uncharacterized pr... 188 3e-46 1 21.5% 2:387 1:366 -MSYVFVADDFTGASDTLATLSRGGLAVRLFRDLPPPEALAGLDAWGIATPARSLDREGIAALAARLGAGLADHAPAFLHVKVCSTFDSSPrgNIALLAQGLADALRIRDLALIGGQPSLGRHCIFGTLFARgrIDRHPVMSVHPVTPMEEADLLRHFAALGLHGLELVPRGGRGRGFPRL----------------YDALVPEDVAAAGRDlgRRLLVMGASSVAEAWLA--AHPGRVQQSVPGLPARGPVLVFAGSRSSLTTAQIA---GADGVARLPLPPAHVLADGPEAERARAWARERLTRGQDCILYLTA---------DGTGGIEPARLAKASAGLVARILGDGPAAGLVVAGGDTSSAIVTALAPDWLDHAGDICAGVP-
137 UniRef50_A0JTQ9 4-hydroxythreonine-4-phosph... 187 7e-46 1 22.5% 1:387 1:391 MASVYVQADDFSGAAEVGYCFVQHGLSAQVLLGTGNTATHDgtDVVVTDTHSRGLPDADAGALVAEAFSSPIATAAQVAFKK----IDSLWRGNVRAEV-AALTGLGF-HAVVAGALPQLQRSVRNGQPFVAGTPLAETGLW-HAELAAPPADIPSLLRPEDPASVHTLDLAAVRSG--SLPAKLGALLESGQpvVVADGESVQDLEHVVDALLELGflVGTGGTADVLAQRLAQSARNAQSGTPAdaAKPVLAVVGSASGTAQAQLAQLEARGFtvRLHP---LYAGATGAYQPELAEVRQSLAAGSNVAVTLAAGKVNPAK----------AAGIVRALSTFAAKAAKGSNADLILTGGETAREVLDAVGLHRLVPLAAVQHGAV-
138 UniRef50_Q1ARS9 Putative uncharacterized pr... 185 2e-45 1 21.5% 2:387 1:351 -MRFAIVADDLTGAMDSGVQLAAAGYATAVALQGAPLPPAPDLDAVVAETGSRALPPGEAAARVRAAVGALRKAAI--LYKKV----DSTLRGPVGAEVEAALAASGRERALISPAFPAAGRTTRGGVQLLCGEPVERTGFARDPRTPVRASGLRRLIP----------GVGAVLGTGELADPSRVRRALRRHRLLVADAETDAHLEALVRAVPDpvLWVGSA--GLARALAARYPGPRPAPEGPLPAAERVIAAVGSRNEVAVGQRELLAAAPGVVEAVVGEGGGGAVQEAARALEAGACCALLRP----------------PEAAGGPEAVLRALGEAAAGLVRSLPGAG---LILTGGDTAAAVARELGAGGIRVLRELEPGVP-
139 UniRef50_B8IXF2 Type III effector Hrp-depen... 180 1e-43 1 19.2% 2:387 3:359 -IKVAVLADDLSGGNSVGAEFARQGLATLVavSEVDAAVRYGPEIIVVTTDTRNRSPEEADAITRDALTRAVTLQPAYLFKK----LDSLLRGPIAVEAAATMAAAGADSALVVTASPPTGRTTRAGRQLVDGRPLLDVIAALDPGASLATDEVGSFFLACGR-PLRHLDLDTVRAGEIKTGEW-------SGRITIADCETQSDLDRtaAIAADVRLFFGTYGMGASIARLLGRNAGM-----------PVLVIAGSLSEATHRQVLALREEGECTLLSVDAPSTSEE-----------ARRALSAGRDVVLCARPDTLGPSAARLLAprAAASAMEERIARCAEPLLGL-VSGLIVSGGSTADTLLVLMGAHGLVlgSELLPGVP-
140 UniRef50_UPI0001BC9D4A type III effector Hrp-depen... 179 2e-43 1 21.6% 2:274 7:265 -PGLLIIADDLSGAADCAADFASR-IDTHVVLTGNAKDLSG---VIAIDADSRRLDPQQAAEQNRAALQQQSRTGMA-LYKK----IDSTLRGNVASEVDALQGLRG--MALVAPAFPAMKRTTVQGVQLIDGVPVDQSDVWRNE-NLHGTGNLLDLFVAQ-GLRTQWLGLDTLRDS-SRLKTTLRNALEQGVQALVCDAQLDSDLLRLALASvdELFWVGSAGLARHLPHAFGLAEALPIKVEPR---SPVLTVVGSMSRHSQAQADRLAQAS------------------------------------------------------------------------------------------------------------------
141 UniRef50_A4FIE3 4-hydroxythreonine-4-phosph... 174 5e-42 1 20.1% 4:387 6:365 ---VLALADDLSGAAETAAALMSSALRADLALDPGAMVSaaEARALVVDLDTRQSDAERAGAALAHVLAQRGPTGPRVLVK-----IDSLLRGNVAATLSAV------GPAVLAPALPVGGRTVVAGAVRVNGAPLRETTAWGTEPGSAPDS-IAQVLAP---APCRSVSLSEIRRDP---RSAIAESLAAG-RIPVCDSETDSDLDAVVAATPPEVALVGSGGLAAALGRSFRQRKAAPRPEFAPREDRALLVVVGTAEPGASVQVHRLVEAgrSLDLHVDQLAHGDPLPGEIERIADAVRQQ------------PTALRLHAPRGVDPAQSRALVRRLAGTVRRVVTAVEDVDLVLTGGETARKVLDALGVRALRPVAQVHHGAV-
142 UniRef50_D2DXV4 Putative uncharacterized pr... 173 8e-42 1 14.6% 4:386 2:326 ---IVILADDFSGAAELAGIAAARGFKAEVQTRFDPS---SDAEVIAVDTDTRLRSEPEAARIVGGIATQVIAAKPSWIFKKT----DSALRGHVRVEIEGILAATGQCSCLFIPANPSKDRVISQGRYLVNGVPLDQTVFAHDPDHPRRSAVVAELL-------------------------------GHAPRIRVPDVTSMETLLHEASSLTPQTLPAGAADFFTALIGGCVMNPRRHP-------VSRTLLVCGSLAAWDTERAQQMKADGFEVMILPETAYGGELDDGWVQQARHALQGACRLMI----------AIGRPAQRHSAATLTGTLVHAAARISAGLDGMRIA---LEGGATAQAFIRVAGWSRFEVVPEGITGV--
143 UniRef50_C9SA80 Putative uncharacterized pr... 165 3e-39 1 14.0% 2:387 40:390 -PLLVALDDDPTGTQTCHDVNVLTVWDVPTLTAEFSLTRRGSG--FFVLTNSRALHPAPARALLVEICTNLRAAsaTGLPFEIVLRGDSTLRGHFPLEAEAATAALGpdAWLLCPFFLQGGRYTVDNVHYVAevPAAQTPFAADATFGYASS----------------TCATTPATGRDAFSTARAPRSCRRGSA------------------------SSPSRPSRRRSSSWATRTPRLRRLSP---PAGGLIMAGSYVPKTTKQLEHLQRDAGRRAHDRpgAARVGGVAVSGERRASWRraSVAGGRDTLVMTSRG--LVVGADEAASLDIGAVVASALVDVLRGLA-TRPRYVVAKGGITSSDMarGLGMRRARVVGQAAAGVP-
144 UniRef50_A8IH51 Putative uncharacterized pr... 164 4e-39 1 19.4% 1:387 23:351 MTGLRLVADDLTGALDAAIAFVTPGQHVPVYWNAPPSVAPSR---LSIDSGTRETDAASARARVAALLRNITPDADTLFFAK----LDSLLRGQAAAEIAAWMEALQPRRCIIAPAFPRQGRVTRGGIQY---------------------------LCRDGAERPVGADLRATLEAEGHPVHLRRPGEAMPEGVSLWDSETDTDLAQIVAAGRPatLWCGSGGLAAALTGH-----PSGIDVAPRTLPRPILGLFGTNHPVTVAQLAACGDAVLALSADGPDNAAALGNKLAADGVALARLALPEGTPRPV--------------------AAARIAEAFSSLVAQL--DPPGTLIVSGGETLRSLCAALGAERLDLYGQIESGVP-
145 UniRef50_B8IX68 Type III effector Hrp-depen... 160 1e-37 1 20.9% 1:387 1:325 MPSLRLIADDLTGALDTAAGF--TGLVGAVEVAWVGAPMGPCGGNLALDTGTRERSAEEAARIAGALAPRLQ--GAEIAFKKV----DSLLRGPWAAELAACFGTGAWRHAIVAPAFPYQGRRTVEGRQFART-------------------------ESGWQAASGDIAESLHAAGLATRRAGVGDGLLDG--VAVYDATDDADLDRiaESAAGPVLWCGSGGLAGALAG-------RSPASCDTRLVGPVLGLFGSDRPETAAQLAHCPEHRLILP------AEGDHAGRVAARLRERGAALVSLG---------------LPEGTGRQEAAARIAASFGLLARAL--PPPGTLLVAGGETLKALCLALGTETLVVTGQVAPGIP-
146 UniRef50_A5FXM3 Uncharacterized protein-lik... 160 1e-37 1 18.1% 7:387 8:336 ------VADDLTGALDAAVQFTGRNPGLPVLLRARNGAPVAETAA--ISTASRDLDADAAGRLMAAAAPFLARAGLRFL------KIDSLLRGHWPRDLAILLGACPDHVCILAPAFPAQRRITRNGRQYA---PGADGILAALPRSPGEELALAGCRARHIPAGALRAADLAAAPGT----------------VLICDALVQEDLDrvARDHGAPILWCGSAGLARALAG--------EGPCRIVPEPGPQLILIGSDHPVTHAQIAAV----------PPSAAARVALGTDGERAASLVAQSLARTSCIV--------TADLPRGLAPAEAAPMIAARLAATLPRL--PRPSGLVVIGGETLASVCNVIGAEALCLAGEILPGVP-
147 UniRef50_Q21A65 Putative uncharacterized pr... 158 2e-37 1 18.7% 3:387 16:341 --RLCLVADDLTGALDTAAQFVSVSSPISVCWGDAALD-----RSVAFDTGAREKSGAEAAALVAERLAQTPHDPSALHYAK----LDTLLRGHPAEEIAAWLRSGAFVRCIVAPAFPHHGRITRQGRQYRRH-GDSWTAVA---------ADLTKDLERLGFR-----------------VAARCPGAPAPDGISLWDAETDADLDAIVAAARapTLWCGSSGLAAALARSL----GAPPSRAATNLVRPVLGLFGSDQPVTADQLAACGG---------VALAAPDGGAAIAKDIAERL-----SRDGVALVSL------AIPDGAPRPQAAATIAREFGRLVREMA--PPSTLLVAGGETLRALCAILETDHLELVGQTEPGVP-
148 UniRef50_A8MD95 Putative uncharacterized pr... 158 4e-37 1 15.3% 1:386 1:307 MVRFMVISDDLTGANGVAGMMSKH-CSVIVINHRLIKLIPGDAECVVVNTESRLIEPDIAESRVKSVISYAEYNG-----FIIGKRIDSALRGNIGPELRPLLKRT----MVITDTIPEYGRFTEGGFTILGDSKVS-------------------ILERLGGIRAMVTSIRGLKANASNLK-----------GVVIVDSRTMSDIAEIAQVIHDNGFTAVDPGPLNA--QVAGLYVKGKLSKHTINRVERVCFIIGSTHENTIRQIERAKRNG----IRVINIRDSTDLSSYDNVIISFDLMKDKDY---------------------------LNEDFIKQAAQ------FDALVVSGGETANLLINVSKANYLESIGEVMPLV--
149 UniRef50_A9LFJ8 Pyridoxal phosphate biosynt... 155 3e-36 1 24.0% 4:228 27:270 ---VVIIADDLTGACDTGLAFSKQGLRTRVYLPPFQGAESGQssVLAFSAESRNGSKEEAASrvETAVEHVSSSGFALLYKKV----DSQLRGNPAVEVSAVLTTSTLAWAVVAPALPSAGRTTVGGYCLQYGVPVNR--LSKDHIASCHNAHIPTLLQEEGFC-TTHISLGDIAHGVDHVASLMSEaaALAGKCVVCDACSEDDLMTVAMAAKqaPVLVGSAGLASA----------------------------------------------------------------------------------------------------------------------------------------------------------------
150 UniRef50_Q02C15 Putative uncharacterized pr... 154 5e-36 1 17.9% 2:387 1:285 -MECLLIADDLTGACDAAVHFAGA--------QVLIDREAQGSRVVAISTESRDLAPAEIRRAWAMAAGQFSA---GLIFQK----IDSTLRGNTAVEIAAAMEAFRCDEAVVCPAFPAQGRVVEGGWLRINGAP---------EFSPID-------VAARIQVPCSDASSDDDLDGI------VARNFGNGRRV----------------------LWVGSAGLASALAR----RIGNLRELKAVVRKGPALFCIGSDHARTLAQQAALLSERAAVQADSREAI---------------CAALSRGQHVVLRIRRGCGTVREL-----------------------IGGAPAAALVLSGGDTASLVCAAAGVRRIELCDEIVPGVP-
151 UniRef50_B1ZNR4 Putative uncharacterized pr... 149 2e-34 1 18.0% 4:386 2:326 ---IVVLADDISGAAELAGAALRRGFSAEVQTSFQPDT---EAEVVCVDTDSRSLAPQAAEAVVAAIARQVAAARPDWVYKKC----DSVLRGHVRRETQAVMAALNRRRAVLVPANPSRGRVVRNGEYFVGEQPLDQTEFARDPEHPRTTARVAELLG------------------------------GELTGVVVPNTETPGDVDAHAFGLDETTLPVGGVDFFEalRRRGAARAAVSAGSAASAGNGSVLVVCGSAAAWS---VRRAEARARGVAVFP----QPHDVAAICAAWRAARTALIGIGDGPATSGRSP---------------GELVSALAGTVVEVVRRIETDRLLLEGGATAAAVVRALGWTRLRACEVAASGV--
152 UniRef50_UPI0001AF32A3 putative inner membrane pro... 147 6e-34 1 19.4% 74:387 6:241 -------------------------------------------------------------------------SGCAVFYK----TVDSTLRGNIAEELEACFAASGRRSLVFAPAFPQAGRTTVGGIQFVDGIPVSESVYGQDPVHPARHSALVDLVPNCIK------------------------------DVTLLDAVTQEELDAQIASIEDPelWLGSPGMAVALARRFV--PAKTAPQLLDCISNDVLVVIGSANPRSHRQADLVRELSSVTLLRGPATRERDPAAVLRRIADDAARELQD--------------------------------------------TRFGALIATGGDTMEAVLDLLNVREFEVLQELEPGFP-
153 UniRef50_Q6W275 Putative inner membrane pro... 147 7e-34 1 17.4% 2:387 3:316 -IRVAIVADDLTGALDTGTPFVDAGLSVAVALDvvEAAIATGAEVVVVNTVSRALDPLQAADRVSQAAAALCRASPEFVLKK----IDSRLKGNVAGESEALALAMGRERLLVAPAVPDQGRFTRETR--VVGFGVAEPL----PIAPLFSARAMDLQ--------------------------------------IADAASDGDLDAIVESLD---WATTAAVGARGLGRALARRLARASAPAPFEPSPRTLFAFGSRDPITETQMAVLLESGLV----------------AAHRDAPAGELPSDGKPALLPMLLRCTGALTGAQETVAERFGEGVSRIVATTLPDM-------LMMGGGDAAYAILRSLGARVLLPRGEIEAGIP-
154 UniRef50_A6UGK8 Putative uncharacterized pr... 145 3e-33 1 17.8% 4:386 12:318 ---LVILADDLTGALDSAAPFAGRGLHTEVALALedAALADQPEVLVVNVKSREVSPDEARMATSDVLKHVPDDA--RIFKKV----DSRLKGNIEVELDAIR----YNRALVAPAIPDFGRVVAGGH--VRGFGVNAPI-------PIAE-----------------------------------RLGRHAESALIPDTTSRDDMLAAVETGEAAglMIGARGLAEALA---HRMTGGAGLPLMSVPQEPILIVVGSRDPITVEQVGVLREDYAVGYFPAV------------------------GGRVQQEAGRPAEMVTVIQAVEGEMPLSPsvSVNLAESVVPAFTGRASTLLLTGGATAEAVLARLGVSRFRLLGECMPGM--
155 UniRef50_A6TIL1 Putative uncharacterized pr... 142 3e-32 1 55.6% 181:387 7:214 ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------VAAALAAVNDPAVRYVVLDALSEQDLLTQGVALREMKLVSGGSGLAIGLARDWAQRHGARGeqAGMPLAGPAVVLSGSCSVMTNSQVAAYRQQAPARAVDLSACFT--DLESYVRTLTDWVDAQRDalAPMIYATTEPQTLQRIQAQYGDKASSERVEQLFAALAAALKANGFTRFIVAGGETSSIVAQTLGVEAFHIGPTISPGVP-
156 UniRef50_C9TIK4 YgbK domain-containing prot... 134 5e-30 1 34.2% 3:148 6:151 --RIGIIADDMTGALMVAAYYETAGIRAMVVTEIDAIRDCADETIIIWAGRTRLIDPVEACRQADRAAAAFDAVGCDQVIYKVCASFDSTEQGNIGPIADILNVRYKPENLLFCPGFPKFNATVHQGYLFYRSRLVSESVKRYDPATP------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
157 UniRef50_UPI0001B5147A 4-hydroxythreonine-4-phosph... 125 3e-27 1 20.1% 4:387 19:367 ---VLALADDLSGAAETAVALRS---PARILLGppEPVAAEPGEALVVDLDSRQLPGAKAARAVRDATHAAPA--GTVLFKK----IDSLLRGNLAAEAAAYAQ--DGAGVVIATALPAARRTVLGGVVRLDGTPLHETDAWRAETRPAPLS-VADALGDLSSAPV---PLTVVRGAPGALREALRARFAHD-RHPVCDAETEADLDAIAAAagPGVRLLGTGGLAGALGRLLGTPVPARLAPYAGDSVRPLLVVVGTAEPSARGQVAHLVADG---------------AHHVALGTRELLRSPRRLAPPV-----APVTVVRITGAASPALARRLVAALADTVADAAQG---CDLVLTGGETARRVLDGLRITDLRPVGQVHHGAV-
158 UniRef50_C1YMK1 Uncharacterized conserved p... 117 5e-25 1 31.6% 181:386 1:191 ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------MRDAIARAGAQGARFVVVDALTDADLRTLADATRDLRLLTGGSALAQGLTG-----PHGTGRLPLTPPRGPRVVLSGSASRATQGQVRHALAHGGGHHLLPSDLRRDFG----ATVSLAVERALEGGASpvVYATAAPEHVVDTAD-------APLIEEALAEIAARLVAAGARALLVAGGETSGAVVRRLGVASLALGPEIDPGV--
159 UniRef50_A3PP83 Putative uncharacterized pr... 112 2e-23 1 17.1% 3:387 28:329 --RLAIVADDLTGALDAGAGFAMRGARVRVARSLTdeALASGAEVIALSTGTRDLGVAEAQARLAEVRALLGAQ--PLLFKK----IDSRLKGPIAAELAALLEG-DPRPILATPAIPALGRFCEAG-----------------------------------------------AVTGAGVDRPIAVAPALGRPARVIDARTDAEIeaLPDDLAAQVFVGAAGLAAALARRLWPGAASTRTHLLST----PALFAIGSRDPVTLAQIAA----------------------------PHALPIRDAPNGAVPALPATDALLVRMTPAEPACPAAVAGDTFARGIAASMAARPVATLFACGGESANAILAELGIGQLDLLGELLPGIP-
160 UniRef50_UPI0001B4E9BD hypothetical protein SgriT_... 103 9e-21 1 22.3% 4:250 9:275 ---VVALADDLSGAAEVAALL---GLPARLALRPADLGlpAPGEAVVVDLDSRYLDEGaaEGRAFRAVNSGAVDGGPLWFKKC----DSLLRGPVGA--EAAAFAEDAEVLVVATALPAARRVVCGGVVLVDGVPLHESAAWRAEERAAPRS----VAGALAPLPVTGVPLETVRRGPIALAGRFREVAADG-RHPVCDAETDTDLTVIATalGPGVRLLGSGGLAAALGRLLTSRRPTPPSAGTRSPAA------------------------------------------------------------------------------------------------------------------------------------------
161 UniRef50_C9THW4 4-hydroxy-3-methylbut-2-eny... 86 2e-15 1 54.9% 2:92 1:91 -MRLGVIADDFTGATDIAGFLVGNGLRTIQLNGVPADDLAVDADAVVISLKTRSCPTGQAIAESLAALKWLQKKQLPAIFLQILLHLRQHAK--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
162 UniRef50_UPI000038E41C hypothetical protein Faci_0... 66 2e-09 1 17.5% 2:127 1:112 -MLTIIISDDLSGAAGMASLIAPH-IPVVPYNRLHD-HGKPDSEIVSIDLETRNlpRLDMVKHTFPGARILA-------------RIDSLFRGS---TLDFVAFIAEYGNILLTDTIPEYGMYTFNG---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
163 UniRef50_D2Y3W3 YgbK (Fragment) n=7 Tax=Ent... 53 2e-05 1 58.6% 330:387 6:63 -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------PSASSERVEHLFAALAAALKVNGFTRFIVAGGETSSIVSQTLGVEAFHIGPTISPGVP-
164 UniRef50_UPI000190527B hypothetical protein RetlK5... 45 0.004 1 20.6% 354:387 2:35 -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------TGLFLTGGDTAESVLSELAFNSLELLSEVEPGIP-
165 UniRef50_C7Z530 Putative uncharacterized pr... 42 0.039 1 19.2% 92:258 477:616 -------------------------------------------------------------------------------------------RTHIDHVKSAAEDAFGGAGLPLSPATPEGKR---NGGQRAAGIHAD----SRHMTEIEADAFIAGFLPP--AYASVAATLREVRKRVG--SEWLQSKLKDGTGLSVLDAGS------------------GGAGLieIVRAEWDLLIENGQVKGSDPPGKRT-VVVGS----------------------------------------------------------------------------------------------------------------------------------
consensus/100% ....................................................................................................................................................................................................................................................................................................................................................................................................
consensus/90% ...hhhhsDD.oGs.t.h...........................h.h.htsR......h.t....hh..h................DS..pGph....thh.t......h.hhs.....tRhh..s..hh.......s.h..........s.h..hh.....................................hh.s....tph..hs.......h..s...............................hhh.GS....s..Qht.h......................................................................h..h.........t.hh.tGG.h...hh..ht...h.....h.....
consensus/80% ...hhhlsDD.TGutssh..h...sh.s.hhht....t...t.tshhh.hpoRths.ttAht...thht.h.t.t...h.hh.....DSs.+Gphs..hpshht.ht.thhhhhsuhPt.tRhshtuhhhhtth.htps.htpc.h.sh.pu.l.thlt.t....h..h.h..h......h..........t..hhlhDs.p.tcht.hsthh.t..hhhsssshh..h......................hhhlsGShs.hottQlt.h.tt.....h.....h...........h.t......t....hhh.............t......s.hhtthhs.hh..h.....thlhhtGG.ss.thhtththtththhtth.shh.
consensus/70% ..lhhluDDhTGupssss.hhttGhpshhhht..t.t..tthpslslsspoRshsstpAhttshthhthhtt.s.t.hhhph...hDSohRGslu.thcshhptht.thhllsPAhPt.GRhshtGhhhltsh.htco.htpcshhshtpupl.phlttpsth.hh.lsht.ltts..thtt.htt..tts.thhlhDu.sppclthlutthhp..hhsuuuuht.tlst.ht...............t.hlhlsGShs.hoptQlthh.ttt.hh.lt..thh..tt..t.ht.hhthh.t..ttttshlh.st.....hthttths..thuthltthhutlsttlhttthttlhhsGG-TuttlhptLthpthplhspl.sGh.
|
MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown